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Abstract 
As nations are encouraged to move towards achieving Universal Health coverage (UHC), access to 
essential medicines needs to be prioritized. In ensuring access to medicines, an important factor to be 
considered is the uninterrupted availability of essential medicines at the primary health care (PHC) level 
which is usually the first point of entry into the health system for patients. If South Africa is to move 
towards achieving UHC, the government must address the issue of unavailability of medicines due to 
frequent stock outs at the public health facilities. The increase in prevalence of HIV/AIDS and TB has 
resulted in an increase in the demand for medicines used in the management and treatment of these 
diseases. Surveys have revealed the extent of stock outs and shortages of medicines used in the 
management of HIV and TB in South Africa. It has also been predicted that the burden of disease in 
relation to these diseases is likely to increase in the coming years therefore, it is important for the South 
African government to address the issues of stock outs.   
Using a qualitative multiple case study approach, we explored the factors which may influence the 
management of medicine stock thus causing medicine stock outs at four PHC facilities in two of the 
districts in the study province. A conceptual framework on the factors influencing medicine stock outs 
at health facilities was developed from reviewing literature on the subject and this was used to guide 
data collection and analysis. Our findings revealed that the factors influencing the management of 
medicine stock leading to medicine stock outs include the lack of capacity in terms of human resources 
and physical resources at the PHC facilities. Insufficient supervision and support from the district level 
also had an influence as health workers at the facilities did not always follow the recommended 
procedures for medicine stock management. We also found that there were gaps in communication 
between the health workers at the facilities and stakeholders at other levels, particularly the 
pharmaceutical depot from which the facilities obtained their medicines. The inadequate information 
systems contributed to this gap in communication.   
Whilst many studies have focused on the factors that may influence the availability of medicine at 
higher levels, this study focused on what may influence it at the ground level, the PHC facility level. 
We anticipate that our findings will inform policy makers on how the availability of medicines at PHC 
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As medicines are an essential building block in health systems, it is important for countries aiming to 
strengthen health systems to pay attention to issues related to medicines (Bigdeli et al., 2014).  Common 
weaknesses in this building block are medicine shortages and stock outs which can adversely affect 
other functions such as service delivery in the health system (Bigdeli et al., 2014). The causes of 
medicine stock outs are widespread as the supply chain for medicines is a complex process involving 
many stakeholders (USAID: Deliver Project, 2011). The complexity of the processes used in the supply 
chain of medicines is partly responsible for the stock outs that occur (Hensen et al., 2011). However, 
measures can be put in place at the health facility levels where services are delivered to reduce the 
occurrence of stock outs (USAID: Deliver Project, 2011).  
The purpose of the literature review that follows is to frame the research question for the study based 
on the existing knowledge on the factors influencing medicine stock outs and shortages. It also informed 
the development of a conceptual framework to be used in guiding the process of data collection.   
Peer reviewed articles on research that has been carried out around the topic on medicine stock outs and 
shortages were searched for using the PubMed database. Most of the articles found focused on medicine 
stock outs of essential medicines. Only articles in English were considered and these included one 
systematic review. The abstracts of the articles were read in order to ensure that they contained relevant 
information for the study topic. The keywords used in the search were "drug stock outs" OR "drug 
shortages" OR "medicine stock outs" OR "medicine shortages" using the filters "LMICs" OR "Lower 




2 Literature review 
Access to essential medicines 
Essential medicines are defined by the World Health Organisation (WHO) as those medicines which 
respond to the most pertinent health needs of a population (Bigdeli et al., 2014). These medicines are 
the foundation for most public health programmes that are aimed at reducing morbidity and mortality 
(Pecoul et al., 1999). Essential medicines and medical technologies have also been widely referred to 
as the core elements of the health system and are said to have great potential in promoting health equity, 
achieving Universal Health coverage (UHC) and strengthening health systems as their effects are 
immediate and long lasting (Barrington et al., 2010; Bigdeli et al., 2014). 
The third goal in the Sustainable Development Goals (SDGs) is to ‘ensure healthy lives and promote 
well-being for all at all ages’ and nations are encouraged to move towards achieving UHC (United 
Nations Department of Economic and Social Affairs, 2015). In order to move towards UHC, developing 
countries need to improve access to essential medicines which have remained inaccessible in many 
Lower and Middle-Income Countries (LMICs) for a long time (Pecoul et al., 1999; Bigdeli et al., 2014; 
United Nations Department of Economic and Social Affairs, 2015).  
Access [to medicines] can be understood using three dimensions; (1) availability, (2) affordability and 
(3) acceptability (McIntyre, Thiede & Birch, 2009; Magadzire et al., 2014). Access is an important 
element that needs to be considered when strengthening health systems (Bigdeli et al., 2014; Magadzire 
et al., 2014). Availability is defined as the fit between the quantity of medicines on hand and the actual 
need of the medicines (McIntyre, Thiede & Birch, 2009). It speaks directly to the absence of medicine 
stock outs and shortages. The availability of medicines is critically important in ensuring access to 
medicines as it would be of no use if medicines were affordable and acceptable but not available.  
Unavailability of medicines as a barrier to access to medicines 
The WHO states that essential medicines should be available at all times in an adequate health system 
(Bigdeli et al., 2014). In many Lower and Middle-Income Countries (LMICs), the availability of 
essential medicines has been poor particularly in the public sector (Bigdeli et al., 2014). In southern 
Africa, household surveys estimated that approximately 20% of patient visits to public health facilities 
end with patients unable to receive medicines due to stock outs and shortages (Wagenaar et al., 2014). 
The unavailability of medicines has been found to be one of the important barriers to accessing essential 
medicines in South Africa (Magadzire et al., 2014). 
Medicine stock outs can be defined as physical unavailability of a medicine required for patient use and 
medicine shortages are situations where the stock available is less than that required for patient use 
(Stop Stock Outs Group, 2014). One of the biggest frustrations faced by clinicians working in rural 
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public facilities is the unavailability of medicines (Stop Stock Outs Group, 2015). The literature reports 
various causes of medicine stock-outs and shortages which seem to be more pertinent in the lower 
income countries and smaller public health facilities such as clinics (Schouten et al., 2011; Bateman, 
2013; Wagenaar et al., 2014). The causes are linked to problems embedded in the pharmaceutical 
procurement and distribution systems (Pecoul et al., 1999; Bateman, 2013). It is thus very important to 
continually asses and improve medicine supply systems to ensure uninterrupted access to medicines 
(Lufesi, Andrew & Aursnes, 2007). The more complex the medicines supply chain is, the more likely 
that it will be inefficient and medicine stock outs will occur (Hensen et al., 2011).   
Supply chain management of medicines 
The medicine supply chain includes procurement, shipping, storage and ultimately dispensing 
medication to the patients and weakness along this chain can lead to stock outs and shortages (Berger 
et al., 2007; Lufesi, Andrew & Aursnes, 2007; Harries et al., 2007; Schouten et al., 2011). Factors along 
this supply chain that are associated with stock-outs and shortages include, manufacturing shortfalls, 
errors in ordering, delayed or changing procurement strategies, difficulties in transporting, sudden 
increases in demand for products, inadequate funding and staffing as well as exploitation of national 
goods (Ketikidis et al., 2006; Berger et al., 2007; Harries et al., 2007; Schouten et al., 2011; Bateman, 
2013; Hasselback et al., 2014; Wagenaar et al., 2014; Stop Stock Outs Group, 2015). Open tender 
systems are widely used to procure medicines as they may be beneficial in terms of costs however it is 
advised that they be avoided or considered together with other strategies due to the fact that them may 
result in unforeseen delays that governments have little control over (Kangwana et al., 2009). The 
reliance of programmes such as malaria programmes on donor funding to purchase medicines can be 
problematic as this funding is not always a reliable and sustainable source of revenue (Pasquet et al., 
2010; Mikkelsen-Lopez et al., 2014). Where governments are not prepared for cases of donors 
withdrawing funds, stock outs have occurred and it is advised that governments ensure that buffer stock 
is always available especially for essential medicines for such unforeseen circumstances (Harries et al., 
2007; Pasquet et al., 2010; Mikkelsen-Lopez et al., 2014).  The aforementioned problems may occur at 
health facility level or at the central level where facilities order from but there are some which are more 
specific to health facilities.  
Supply chain management of medicines at health facilities 
Non-existent or poor stock control including poor forecasting are the major causes of stock outs and 
shortages reported in literature at the health facility level when stock is available at the central or depot 
level (Barrington et al., 2010). In a study by Lufesi et. al (2007) in Malawi, some discrepancies were 
found between the reported stock levels and actual stock on hand at health facilities implying that the 
health workers were not following protocols on the management of medicine stock. It was suggested 
that this non-compliance could have been as a result of lack of training and supervision from seniors 
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such as district pharmacists (Lufesi, Andrew & Aursnes, 2007). Another reported reason for non-
compliance to protocol is the capacity of the health facilities themselves to store sufficient stock of 
medicines including buffer stock. The management of medicines supply is essential for the provision 
of health care and even more important in lower income countries where resources are scarce as it has 
also been reported that one of the major areas of wastage in the health system occurs in the use of 
medicines (World Health Organization, 2010; Schouten et al., 2011).  
The effects of unavailability of medicines 
The consequences of medicine unavailability are widespread and can have detrimental effects on 
individual and public health (Harries et al., 2007; Barrington et al., 2010). Unplanned treatment 
interruptions could lead to an increase in resistance for example to antimicrobials and antivirals which 
can have the ripple effect of switching to more costly treatment and interventions (Harries et al., 2007; 
Pasquet et al., 2010). Such adverse effects have been documented from antiretroviral (ART) clinics in 
sub-Saharan Africa (Harries et al., 2007). Another important consequence of the unavailability of 
medicines to governments is the loss of confidence in public health systems by citizens (Magadzire et 
al., 2014; Wagenaar et al., 2014; Honda et al., 2015). Patients may have to travel to alternative facilities 
including the private sector facilities to source medicines (Pasquet et al., 2010). This may be costly and 
becomes a barrier to accessing medicines (Magadzire et al., 2014). In order to address the challenges or 
medicine stock outs and shortages, countries have introduced various systems targeted at the different 
causes of stock-outs.  
Strategies to ensure uninterrupted availability of medicines 
As technology advances in Africa, some countries have taken advantage of this and upgraded their 
medicine management systems from paper based to computer and web-based systems as a measure of 
mitigating medicines unavailability (Berger et al., 2007; Githinji et al., 2013). The successful 
implementation of web-based systems has solved the problem in Haiti where obstacles existed with the 
paper based systems (Berger et al., 2007). This system facilitated communication which is vital for the 
management of stock levels between stakeholders involved in the processes (Berger et al., 2007). In 
Kenya, an SMS for life was implemented for anti-malarial medicines and it also solved the problems of 
unavailability of rapid diagnostic tests and anti-malarial medicines by enhancing stock visibility 
(Githinji et al., 2013).  
In South Africa, a software programme, Rx solution has been introduced in some public health facilities 
to support the regulation of stock control in public health facilities (Health Systems Trust, 2015b). 
Another programme that has been implemented in South Africa to address the issues of drug stock outs 
particularly for chronic diseases is the Central Chronic Medicine Dispensing and Distribution 
Programme (CCMDD) (Health Systems Trust, 2015a). The aim of this programme was to reduce the 
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burden on Primary Health Care (PHC) clinics and increase the availability of medicines for chronic 
conditions which are becoming more prevalent in South Africa (Health Systems Trust, 2015a).  
The importance of ensuring uninterrupted availability of medicines 
A survey revealed that essential medicines used for chronic conditions were more prone to stock-outs 
than those used for acute conditions (Bigdeli et al., 2014). In the recent past years, there has been a 
considerable increase in the prevalence of both communicable and non-communicable diseases (NCDs) 
world-wide (Mayosi et al., 2009; Magadzire et al., 2014). NCDs have become the leading cause of death 
as reported by the World Health Organization (WHO) report in 2014. This increase has led to an 
increased demand for essential medicines used to prevent and treat these diseases (Mayosi et al., 2009; 
Magadzire et al., 2014). The higher demand has placed a huge strain on the health sector of South Africa 
which serves about 70% of the country’s population (Magadzire et al., 2014). It is evident that 
availability of medicines used to manage these conditions needs to be improved as it has also been 
predicted that the burden of disease in relation to NCDs and communicable diseases such as HIV/ \AIDS 
and tuberculosis (TB) is likely to increase in the coming decades (Mayosi et al., 2009; Health Systems 
Trust, 2015a).  
3 Study rationale  
The progress on improving access to essential medicines has been slow even though many LMICs have 
included the access to medicines as part of the right to health in their constitutions as it has been widely 
acknowledged that medicines are the most effective way of preventing death once disease has been 
established (Habiyambere & Wertheimer, 1993; Wagenaar et al., 2014; Bigdeli et al., 2014). Section 
27 of the South African constitution states that citizens have the right to access health care therefore it 
is essential to consider aspects such as the availability of medicines that have a direct impact on access 
to health care. In South Africa, surveys have revealed the extent of drug stock outs and perceived causes 
of stock outs by health workers (Stop Stock Outs Group, 2014; Stop Stock Outs Group, 2015; Public 
Service Commission, 2015). From these reports, it is suggested that one of the reasons why essential 
medicine stock outs and shortages occur at the PHC level is because of the poor fore-casting and poor 
management of medicine stock by the clinics (Stop Stock Outs Group, 2015).  
In light of the evidence of poor supply chain management of essential medicines in the public health 
facilities and frequent problems of drug stock-outs or shortages in South Africa, the search for an 
effective management system is a priority for the current government (Public Service Commission, 
2015). A Discrete Choice Experiment (DCE) on improving the public health sector in South Africa 
revealed that the availability of medicines at health facilities has the greatest impact in the probability 
that people will attend public health facilities (Honda et al., 2015). South Africa is moving towards 
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implementing the National Health Insurance (NHI) in the coming years as a bid to move towards 
achieving UHC. The white paper released mentions the need to address the quality of healthcare of 
which availability of medicines is one of the areas that need attention. Access to medicine needs to be 
improved especially in the Primary Health Care (PHC) clinics which are usually the entry point for 
citizens into the healthcare system for successful implementation of the NHI. 
The factors that contribute the most to the occurrence of stock outs of medicines in South Africa include 
inadequate health workforce particularly pharmacy personnel, poor medicine stock management, and 
inefficient communication between suppliers, depots and health facilities (Bateman, 2013). The 
inefficient communication between the depot and health facilities is a problem because in some cases 
the clinics do not warn the depot well in advance that they will require larger quantities of stock than 
the usual quantity and thus the depot is unprepared and unable to meet their needs (Bateman, 2013; 
Stop Stock Outs Group, 2015). Each public health facility including the PHC clinics are required to 
sign a ‘terms of agreement’ contract with the pharmaceutical depot which outlines the way in which the 
two interact in terms of the ordering and supply of medicines.  
This study will explore the supply chain management of medicines at clinics in two health districts 
focussing on the processes involved as well as the way the actors involved in the processes interact as 
they carry out their roles. It is hoped this research will contribute to policy review and formulation of 
standard operating procedures for the management of medicines focusing on how to prevent medicine 




4 Conceptual framework 
The conceptual framework in Figure 1. illustrates the factors that influence the medicine stock 
management processes at health facilities and thus could be responsible for the occurrence of medicine 
stock outs at clinics. This framework has been informed by the literature review however we are aware 
that other factors may be found during the study that have not been included in the framework developed 
for use in this study to guide the collection and analysis of data. We were not able to identify any pre-
existing theoretical frameworks that could be used for this study hence empirical literature was used to 
develop the conceptual framework.   
  
Figure 1: Conceptual framework showing factors influencing the management of medicine stock at 
PHC clinics which in turn has an influence on the availability of medicines at these facilities. 
 
Ensuring medicines availability is an important goal for health systems as medicines are an important 
building block in the health system (Bigdeli et al., 2014). Some of the factors influencing the occurrence 
of stock outs at the health facility level stem from the way in which medicine stock is managed at health 
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facilities and could be as a result of the inventory control methods used, information and reporting 
systems used, capacity of the health facilities as well as health workers and communication between 
key actors in the processes (Harries et al., 2007; Lufesi, Andrew & Aursnes, 2007; Barrington et al., 
2010; Githinji et al., 2013). Supply chain management of medicines includes all the processes and 
activities involved in sourcing medicines from the pharmaceutical depot and ensuring adequate stock 
levels at the clinics (USAID: Deliver Project, 2011). These are shown in the conceptual framework in 
Figure 1.  
Inventory control of medicines includes the placing of orders from the pharmaceutical depots as well 
as how the stock levels are maintained at the health facility to ensure uninterrupted availability of 
medicines (USAID: Deliver Project, 2011). Forecasting is another important aspect of inventory control 
as it is used to determine the quantities of stock that a facility may potentially use in a certain time 
period in the future (Harries et al., 2007; USAID: Deliver Project, 2011). If a structured system for 
forecasting exists, the occurrence of stock outs is likely to be reduced (Harries et al., 2007). In order for 
facilities to be able to order stock from the depot, communication between the facility and the depot is 
required. The manner in which clinics communicate with the depot may have an impact on the supply 
of medicines at the clinics if information is not shared (USAID: Deliver Project, 2011).  
Information systems refers to the technologies that may be utilised by health facility staff when 
managing the levels of medicine stock (Barrington et al., 2010; USAID: Deliver Project, 2011). These 
may be electronic or paper based which require different levels of skill and expertise to use them well 
(USAID: Deliver Project, 2011). Information systems may be linked to the way in which information 
will be shared between the actors involved in ensuring the availability of medicines (USAID: Deliver 
Project, 2011). Literature suggests that information systems may facilitate efficient communication. 
The information systems also include the systems used by clinics to report to their district and provincial 
managers.  
The capacity of health workers and health facilities refers to the extent to which the health workers are 
qualified and able to manage medicine stock as well as the extent to which the facility they work in 
allows them to do so appropriately (Lufesi, Andrew & Aursnes, 2007). The capacity of the heath 
workers and the health facilities will also enable them to communicate appropriately with the depot, 
carry out inventory control and use the information and reporting systems available to them. This shows 
that these factors are interlinked and together influence the process of medicine stock management at a 
health facility.  
There may be other factors which may not be directly linked to the process of medicine stock 
management but may still influence the process. Such factors may be factors related to the context in 
which the health facilities are found. Health facilities ay be located in different areas such as districts, 
sub-districts or provinces. These facilities can be said to be embedded in different contexts as shown by 
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Figure 2. Context is an important aspect when carrying out case study research (Yin, 2003). One of the 
definitions of a case study states that in is an inquiry about a certain phenomenon within its context 
especially when there are no clear boundaries between the context and the phenomenon itself (Yin, 
2003). This implies that there will always be contextual factors and it is thus important for this study to 
recognise and consider contextual factors that may have an impact on the management of medicine 











Figure 2 Illustration of health facilities as cases within the two different district contexts within the 
same province (adapted from Yin, 2003).   
 
In the management of medicine stock at the clinic level, contextual factors which may influence the 
process include, the geographic location of the clinic, the district as well as provincial management 
teams, and the disease burden in the district or area served by the clinic (Lufesi, Andrew & Aursnes, 
2007; USAID: Deliver Project, 2011; Hasselback et al., 2014). Contextual factors may also influence 
the actors affecting the manner in which they carry out their roles. These actors include the district 
pharmacists and the provincial head of pharmaceutical services. Context may be useful in explaining 
differences or similarities in the cases analysed in a case study.  
The geographic location of the two districts illustrated in Figure 1. differs hence the location of clinics 
may influence the way in which medicine stock is managed in a number of ways. It includes aspects 
such as whether the clinic is located in a rural or urban area and also speaks to the distance between the 
facility and the pharmaceutical depot.  The location may affect the communication processes between 
















Context a  Context b 






stock outs and shortages are worse in rural areas where there may be transportation and accessibility 
challenges (Bateman, 2013; Hasselback et al., 2014). A study in Mozambique by Hasselback et. al 
(2014) reported that the further away facilities were from the depots, stock outs occurred more 
frequently. This may have been due to difficulties faced by the depots in transporting medicines and 
accessing the health facilities by road in the more rural areas (Lufesi, Andrew & Aursnes, 2007).  
The geographic location may also have an influence on the health workers that are employed at the 
facilities. Studies have found that health workers are motivated to work in urban rather than rural areas 
therefore the calibre and capacity of workers found in a health facility may be influenced by the context 
in which the facility is found (Lufesi, Andrew & Aursnes, 2007). The capacity of the health workers in 
that region which in-turn influences their ability to follow protocols in inventory control and their ability 
to use information and reporting systems (Lufesi, Andrew & Aursnes, 2007).  
The burden of disease in each district may influence the forecasting process in inventory control as 
health workers manage medicine stock at the clinics. If there is a higher demand for certain medicines, 
their chances of going out of stock are increased depending on the methods used to determine re-order 
quantities (USAID: Deliver Project, 2011).  
The head of pharmaceutical services and provincial management team will be the same for both districts 
in this study however each district will have different district pharmacists as part of its district 
management team. These actors may be influenced by the afore-mentioned contextual factors 
influencing the communication between them and the clinics with regards to stock outs. The actors may 
also be influenced by these factors as their carry out their roles in the management of medicine stock 
affecting for example their ability to supervise the health workers at the clinics.  
5 Research aims and objectives 
The aim of this study is to better understand why medicine stock outs occur frequently at public health 
facilities with a specific focus on the PHC level. 
5.1.1 Objectives:  
1) To examine the medicine stock management process at the clinic, with a particular focus on: 
 Inventory control 
 Capacity of health workers and clinics 
 Communication between the depot and clinics 
 Information and reporting systems used in the processes 
2) To explore the role that contextual factors may have on the management of medicine stock. 
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3) To draw policy implications that may improve the management of medicine stock at PHC clinics.  
In order to examine these processes, the study will attempt to identify the actors involved in drug 
procurement and stock management at the PHC clinics, the roles of these actors and the way in which 
they interact and share information with each other in carrying out their tasks. We will use the standard 
operating procedures as a tool for analysing our findings, we will test what staff are doing in clinics 
against the standard operating procedures. This will serve as a basis for reflecting on our findings.  
5.1.2 Study Question 
What are the processes involved in medicine stock management at PHC clinics in South Africa, 
focusing on the factors that influence these processes in District A and District B, In the study province 
as a means to explore and explain how and why stock outs occur at clinics? 
6 Methods 
6.1.1 Study setting: 
South Africa has a total of nine provinces of which the study province has been selected purposively 
for this study. This selection was based on the fact that in 2014, the study province had the largest 
proportion of facilities with stock-outs of ARVs and TB medicines (Stop Stock Outs Group, 2015). 
These medicines are amongst the list of essential medicines that should be found at the PHC level in 
South Africa (The National Department of Health, 2003). The choice to use ARVs and TB medicines 
as tracer medicines for this study is based on the reported extent of stock outs of these medicines in the 
province as well as the high prevalence of HIV in the study province. TB is one of the common co-
morbidities of HIV hence the decision to add medicines used to manage and treat the disease alongside 
ARVs. HIV/AIDS and TB are also amongst the health priorities for the province.  
 The study province has three districts, District A , District B and District C. These districts are further 
divided into sub-districts. District A, which is one of the pilot sites for the implementation of the South 
Africa National Health Insurance and District B which is where the Pharmaceutical Depot is located 
have been selected purposively as the study sites (Health-e, 2015). District A is one of the deep rural 
districts where the communities face challenges in accessing health services (Health-e, 2015). District 
B on the other hand is the economic hub of the study province (District B municipality, 2014). District 
A has 1 regional hospital, 7 district hospitals, 9 Community Health Centres, 59 clinics, and 27 mobile 
clinics (Health Systems Trust, 2016). District B on the hand has slightly more public health facilities 
which include, 1 tertiary hospital, 1 regional hospital, 5 district hospitals, 16 community health centres, 
65 clinics and 22 mobile clinics (Health Systems Trust, 2016).  
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The two districts have been selected purposively to allow for comparisons between districts which may 
give insight into whether there are any contextual factors such as geographic location and burden of 
disease which are unique to each district that may influence the occurrence of medicine stock outs. The 
clinics in District A which is more rural that District B are further away from the depot than the clinics 
in District B. By choosing these two districts, we will be able to explore if distance from the depot as 
well the location in a rural or urban area have an influence on the management of medicine stock 
ultimately affecting the occurrence of stock outs.  
6.1.2 Sampling strategy 
The sample size will be determined by the available time and resources for the study. Purposive 
sampling will be used to identify facilities as cases for inclusion in the study. A total of 2 facilities in 
each district shall be chosen based on their reported proportions of stock outs according to the data 
available at the respective district levels. This information on the extent of medicine stock-outs will be 
sought from the respective district offices. The indicators that will be used to identify the clinics for 
inclusion in the study are the weekly tracer drug reports which every clinic is requested to submit to 
their district pharmacist every week. The clinics in each district that reports the most and the least in 
the average ARVs and TB medicines out of stock on the tracer drug list for the past 3 months will be 
chosen. For the purpose of this calculation, there numbers of ARVs and TB medicines out of stock will 
be combined. The reason for choosing the clinics with the most and least medicine stock outs is to 
enable a comparison of what could be responsible for the difference in the frequent and less frequent 
occurrence of stock outs.  
The case in this study shall be defined as the PHC clinic with an emphasis on the supply chain 
management of medicines which will be the unit of analysis. Within the supply chain management of 
medicines at the clinic level, the study will focus on inventory control of medicines including 
forecasting methods, information and reporting systems, and communication between the depot and 
clinics. Inventory control includes the processes involved when ordering stock from the pharmaceutical 
depot and the procedures followed by PHC staff in managing stock levels of medicines at the clinics.  
In terms of communication, we will focus on how the actors involved at the clinics, within the district 
and province as well as at the depot communicate with each other as they carry out their respective roles 
in managing medicine stock. Another aspect that we shall consider is the capacity of the health facilities 
and health workers to manage medicine stock.  
6.1.3 Study design 
 The study will employ a qualitative multiple case study approach. This study design has been chosen 
based on the aim and the purpose of this study as advised in literature (Green & Thorogood, 2014). The 
purpose of the study is both exploratory and explanatory as it aims to find out whether the health 
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workers at the clinics are following protocols for the management of medicine stock, how the clinics 
share information and communicate with the pharmaceutical depot as well as other stakeholders in the 
process of managing stock and then explain how these may be linked to the frequent occurrence of 
stock outs and shortages within a particular context. The study will also have a descriptive component 
as it shall describe the processes involved in medicines management at clinics. Case studies are useful 
where an extensive in-depth description of a phenomenon is needed which is why it has been selected 
for this study (Yin, 2003; Green & Thorogood, 2014).  
The rationale for choosing this methodology is that it will enable collection of a rich source of 
information in a short time period (Yin, 2003; Green & Thorogood, 2014). Case studies involve 
studying a particular phenomenon within its context (Yin, 2003). Case studies often make use of a 
combination of data collection methods and tools (Green & Thorogood, 2014) and one of the unique 
strengths of this study design is its ability to handle and put together information collected from various 
sources (Yin, 2003). This will be useful in this study as different sources of evidence and data will be 
used. Semi-structured in-depth interviews with key informants and documentary analysis will be the 
main data collection tools.  
 The conceptual framework developed from the literature will be used to guide data collection 
(questions will be derived to help us explore and explain the key concepts in the conceptual framework 
which will ultimately allow us to answer the research questions). Key policy documents will be 
reviewed such as standard operating procedures (SOPs) for medicines management for the PHC clinic 
level and depot level, the South Africa National Drug Policy, WHO procurement and supply of 
pharmaceutical guidelines and other relevant international guidelines on drug stock management. This 
will help us ensure that we formulate questions on communication, forecasting etc. that are relevant in 
the South African context. This will also allow us to observe whether standard operating procedures are 
being followed in our clinic settings.  
6.1.4 Research procedures and data collection methods 
Qualitative data will be collected in this study. Data will be collected from documents and records at 
the facilities which include stock cards, weekly tracer drug lists as well as any other stock management 
records kept at the facility. Provincial and district organograms will be used to identify the key actors 
in the supply chain management of medicines at PHC level who will serve as key informants in the 
interviews. The key informants to be interviewed include the pharmaceutical depot manager, the health 
worker in charge of medicines supply management at the clinics, district pharmacists, and the head of 
pharmaceutical services in the study province. Snowball sampling shall then be used to identify other 
informants who are stakeholders in the supply chain management of medicine at clinics as it may not 
necessarily be the nurse in charge. This will be done in order to gather information from as many 
perspectives on the management of medicine stock at clinics and the causes of stock outs by covering 
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all the major actors involved. Initially, a total of 8 actors have been identified and approximately 10 to 
15 interviews will be held, depending on the additional informants identified by the initial key 
informants mentioned above.  
Data collected will include information that will help to describe the procedures followed by health 
workers at the clinics when ordering and receiving medicines from the depot, how stock levels are 
managed as well as how they respond to cases of stock outs. This will be collected from interviews with 
the health workers in charge of medicines management at the clinics using semi-structured 
questionnaires administered by the researcher. The questionnaires will also include questions which 
will provide information on how the depot interacts and communicates with the clinics and what 
procedures are followed by the depot in response to cases of drug stock outs at the clinics from the 
health workers’ perspective.  
Separate questionnaires for the key informants from the depot, respective district and provincial offices 
will also be used to collect similar information relevant to their positions. Some questions will be 
different for different informants as they have different roles in the management of medicine stock. The 
different groups of informants are vital for this study as there is more than one group of actors involved 
in managing medicine stock to ensure uninterrupted availability of medicines. It is therefore essential 
to identify and involve in this study the key actors involved to gather perspectives from more than one 
angle.  
Interviews will be conducted in English using semi-structured questionnaires which will also be in 
English. These questionnaires will be piloted in order to test their reliability and validity prior to data 
collection to ensure that the data collected is adequate and appropriate enough to answer the research 
question. The interviews will be tape-recorded with the consent of the interviewees. The data collected 
from records at the facilities, interviews and observations will be used to identify and describe the 
methods of medicines management being utilised at the clinics. This will then be compared against the 
recommended standard operating procedures and terms of agreement for the supply of medicines signed 
by the depot and clinics. This data will also provide information on how pharmaceutical depots and 
clinics manage medicine stock outs as they occur at the clinic level.  
6.1.5 Rigour 
There are ways in which qualitative researchers are advised to ensure rigour which is also referred to as 
the trustworthiness of a study (World Health Organisation (WHO), 2012). In case study research, 
measures to ensure rigour include a clear description of the methods used to collect and analyse data. 
This may be done in the form of writing up a research protocol detailing the decisions made in 




In order to ensure confirmability during the phase of research design, a literature review was carried 
out as advised (World Health Organisation (WHO), 2012). This literature review then informed the 
development of a conceptual framework to be used to guide data collection. In the data analysis phase, 
researchers may use different sources of evidence to look for similar and or different experiences within 
cases as well as across cases (Green & Thorogood, 2014).  Where at least two sources of evidence are 
used, this is called triangulation (Green & Thorogood, 2014). In order to ensure the credibility of the 
findings during the phase of analysis in this study, we shall use data collected from the interviews, 
document reviews and observations to compare findings within and across cases.   
Purposive selection of cases to include one ‘positive’ and one ‘negative’ case is also a manner in which 
researchers can ensure rigour (World Health Organisation (WHO), 2012). In this study, the clinics will 
be selected to ensure that there is one clinic reporting high levels of stock outs and one reporting low 
levels of stock outs in each district.  
6.1.6 Data analysis 
Data analysis will be carried out immediately after data collection. The first step in the data analysis 
will be to transcribe the tape-recorded interviews and type out field notes into electronic documents. 
This will be done manually. As data will be collected from more than two sources, interviews, document 
review and observations, the data will be triangulated and this is a way of ensuring rigour in qualitative 
research (Green & Thorogood, 2014).  
The data will be analysed using a thematic content analysis which is the most commonly reported 
method in qualitative health research (Green & Thorogood, 2014). A thematic content analysis presents 
the key elements found in a study and groups them into concepts that can be used to summarize and 
arrange the data in such a way that allows the researcher to put meaning to the findings (Green & 
Thorogood, 2014). The next step in the thematic analysis will be for the researcher to identify codes 
and themes across the data set and this shall be guided by the conceptual framework.  The codes and 
themes identified will then be organised using the NVIVO software to enable analysis of the data.  
7 Ethical considerations 
Ethical review and approval will be sought before the commencement of data collection from the 
University of Cape Town human research ethics committee as well as both the National and Provincial 
Department of Health committees. The approval from the National department of Health will be 
essential to ensure access into the pharmaceutical depots and the health facilities for data collection.   
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7.1.1 Informed consent process 
In as much as the National Department of Health shall provide a letter giving the researcher access into 
the health facilities, fully-informed consent shall be required from the key informants who will 
participate in this study. The district managers in each district shall be informed prior to making contact 
with any potential key informants on the study. Each participant will be provided with a letter of 
invitation to participate in the research delivered to them prior to the initiation of data collection. In this 
letter, they shall be given full information of the nature of the research, use of data collection and what 
participation entails for example the estimated time that the researchers will spend at the facilities as 
well as how long each interview will take. The participants will also be informed that they have the 
right to withdraw partially or fully from participation at any stage during the data collection. As the 
interviews will be tape recorded, the participants will be required to give consent to the recording of the 
interviews.  
The researcher will follow up with the key informants to whom letters were sent telephonically and they 
will be required to give verbal consent to take part in the research. This verbal consent will be 
supplemented by a written agreement signed by both the participant and the researcher. This written 
and signed consent shall be obtained at the health facilities on the day of the interview prior to the 
interview.  
As clinics can be busy places and the choice of venue as well as time of interview can affect the quality 
of data as well as willingness of health professionals to participate in research, the researcher will make 
an appointment with the respective key informants and allow them to decide on a time that is least 
stressful to them as consent will be obtained at their places of work.  
7.1.2 Risks and benefits 
The risks that may be encountered by the participants in this study are minimal. One of the risks as with 
all types of research is that of breaching confidentiality which may be feared by the key informants. In 
order to mitigate this, measures shall be put into place in order to ensure that privacy and confidentiality 
is maintained at all times.  
Since the interviews at the health facilities and depots will be carried out at the informant’s place of 
work, there is the possibility of encountering the risk of lost time for them to carry out their daily duties. 
In order to mitigate this risk, the researchers shall inform the informants of the estimated time for the 
interview such that the informants will be prepared and can plan accordingly well in advance. The 
interviewer shall endeavour to ensure that the interview does not take longer than the proposed time 
and allow the participants to stop the interview should they wish if it has gone beyond time.  
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Participants may not be comfortable with the tape recording of the interviews in fear that their voices 
and words may be recognised if quoted verbatim. In order to address this, the participants will be 
required to give their consent to the tape recording of the interviews and it will be made clear that the 
purpose of the tape recording is to ensure that the researcher captures the information they provide as 
accurately as possible. They will be asked to sign on the consent form specifically if they do consent to 
being recorded. If the participants are not comfortable with the tape recording, they shall be allowed to 
opt out of it.  
There may be legal and economic risks to the participants which may affect their willingness to disclose 
certain information pertaining to the way that they do their work for example if they are aware of 
fraudulent activity. In order to mitigate this risk and inspire confidence into the participants, it shall be 
emphasised that the findings will not be disclosed to the participants’ employers and all responses will 
be kept anonymous. The participants will be given the option to choose pseudonyms and their 
permission to use any quotes will be required before they are included in the research report.  
There will be no direct benefits to the participants and they will not be offered any remuneration for 
participation. All participants will be treated fairly and there will be no penalty for refusal to participate 
as well. A potential social benefit of the research is that the study will potentially inform policy review 
and formulation of standard operating procedures for the management of essential medicines focusing 
on how to handle medicine stock outs in public health facilities. Ultimately these may aid the 
government to deal with the problem of drug stock-outs.  
7.1.3 Privacy and confidentiality 
The researcher conducting the semi-structured interviews will be trained especially on the importance 
of maintaining confidentiality and professionalism. In order to maintain confidentiality of the key 
informants, their names and identification numbers will not be recorded however it will be important to 
identify whether data was collected from a facility nurse or pharmaceutical depot manager for example. 
Special codes only known to the researchers will be used for this. That will be the only identification 
used and it shall not be disclosed. The participants will be given the choice of selecting pseudonyms to 
be used in the write up in order to preserve the anonymity of the interviewees. The questionnaires and 
tape records will be kept in a locked cupboard for the duration of the study and the data once entered 
into spreadsheets will be kept in password protected files. The researchers will be the only ones with 




7.1.4 Use of information and publications 
The findings of this study will be disseminated through a journal article which will be sent to a peer 
reviewed journal and a policy brief. These are requirements in the fulfilment of the Master of Public 
Health, Health Economics dissertation.  
8 Resources/Budget 
The proposed budget for this study is shown below in Table 1. The study will be funded by the National 
Research Fund (NRF) South African Research Chair; Health and Wealth program. Unit costs were 
drawn from the UCT planning and budget guidelines available from: 
https://www.uct.ac.za/usr/finance/notices/budgui13.xlsx. (Accessed 15 March 2016). The duration of 
the fieldwork study was based on a consideration of the number of facilities to be visited and the number 












Travel and accommodation 
Airfare 
Flights from Cape Town to City Y and 
return for two separate field visits, one 
visit in each district.  
2900 4 11600 
Per diem 
accommodation 
Accommodation during fieldwork in the 
study province. Two field visits, ten days 
per visit spent in each district. 
895 20 17900 
Per diem meals and 
incidentals 
Meals and incidentals whilst on fieldwork 
in the study province.  
372 20 7440 
Transportation 
Per diem car hire Travel during fieldwork 600 20 12000 
Fuel per kilometre 
Travel from the airport to the two districts 
for field visits as well as travel to and from 
the facilities during field work.  
City Y-District B: 200x2=400km,  
City Y-District A: 230x2=460km.  
Travel to and from facilities +/-400km 
3,29 1260 4145,4 
Operating expenses, postage, printing, etc. 
 Transcription 
Total of 20 interviews, half to be 
transcribed by myself and the other half by 
a hired transcriber.  
1000 10 10000 
  Printing and 
stationery 
Printing of information sheets, consent 
forms, pens and notebooks to be used 
during data collection.  
  200 
Communication  
Pre-paid airtime and data to communicate 
and arrange interviews with participants.  
500  500 
Total     63785,4 
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9 Project timeline 
The proposed duration of the study is 8 months. Table 2. Shows the timeline for the project.  
Table 2: Timeline 
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The availability of medicines is an essential aspect of access to healthcare especially at the Primary 
Health Care (PHC) level as this is usually the first point of contact for many individuals with the health 
care system. The unavailability of medicines at PHC facilities may be due to frequent stock outs of 
medicines which are caused by various factors. One of these factors being the ways in which medicine 
stock is managed at the health facility. The following section includes the aims and objectives of the 
literature review, the methods used and finally the literature review. We start off by giving an overview 
of access to essential medicines and its importance, we then define medicine stock outs and its impact 
on patients as well as the health system. We then discuss medicine supply chains detailing at which 
point medicine stock outs may occur. This is then followed by the functions within the supply chain 
related to ensuring medicine availability namely, procurement and selection, forecasting, storage and 
distribution of medicines. The following sections discuss other general causes of medicine shortages 
and stock outs and is followed by strategies that have been used to address challenges in medicines 
availability. We then give an overview of medicines availability in the study context, South Africa. 
Lastly we discuss the methods used in the research papers that were included in this literature review.  
 
 AIMS AND OBJECTIVES 
The aim of this literature review was to identify key research that has been conducted on medicine 
availability, medicine stock management and medicine stock outs. The aim was to identify from the 
literature what is known on these subjects as well as identify any gaps in this knowledge which could 
be addressed by further research.   
11.1.1 Objectives: 
1. To review the literature on the ways in which medicine stock is managed and the occurrence or 
causes of medicine stock outs identifying any gaps in knowledge. 
2. To identify strengths and weaknesses in previously used methods in research carried out to 
answer similar questions.  
 METHODS 
Peer reviewed articles published in English were searched for on the availability of medicines and 
medicine stock management common used databases for public health and medicine which include; 
PubMed, EBSCOHost, Google scholar, Scopus and Cochrane. Articles from the past three decades were 
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considered that is from the year 1987. The identified articles were then analysed for relevance (i.e. they 
focus on the medicine stock management, medicine stock outs or medicine availability) by reading 
through the abstracts. To further identify additional papers to include in the review, the bibliographies 
of the papers identified in the step above were reviewed. Grey literature on the subject was included in 
this review. This was identified by searching through websites of the Management Sciences for Health 
(MSH), World Health Organisation (WHO), United Nations (UN) and Google. Unpublished articles, 
reports, conference papers and dissertations were included as grey literature. A review template was 
developed to extract relevant information from the literature identified for the structured literature 
review.  
12 Structured Literature Review 
 ACCESS TO ESSENTIAL MEDICINES  
Essential medicines are defined by the World Health Organisation (WHO) as those medicines which 
respond to the most pertinent health needs of a population (Bigdeli et al., 2014). These medicines are 
the foundation for most public health programmes that are aimed at reducing morbidity and mortality 
(Pecoul et al., 1999). The WHO provides a model list for countries to use which consists of basic 
essential medicines and this list is updated every two years, however the selection of essential medicines 
may vary from country to country or even provincially. The selection of medicines to be considered on 
an Essential Medicine List (EML) is usually based on the most prevalent diseases in that region as the 
selected medicines would have to satisfy the needs of most of that population for them to be deemed 
‘essential medicines’ (World Health Organisation, 2017). Other factors considered when selecting 
essential medicines include the efficacy and effectiveness of the medicines which emanates from 
evidence based research (World Health Organisation, 2002). The costs and cost-effectiveness of the 
medicines are also compared to others which may be used to treat the same conditions and these factors 
are also used to determine which medicines end up on the essential medicines list (World Health 
Organisation, 2002). It is also important to ensure that those medicines chosen for this list are also 
readily available (World Health Organisation, 2002). 
 
Essential medicines and medical technologies have also been widely referred to as the core elements of 
the health system and are said to have great potential in promoting health equity, achieving Universal 
Health coverage (UHC) and strengthening health systems as their effects are immediate and long lasting 
(Barrington et al., 2010; Bigdeli et al., 2014). The third goal in the Sustainable Development Goals 
(SDGs) is to ‘ensure healthy lives and promote well-being for all at all ages’ and nations are being 
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encouraged to move towards achieving UHC (United Nations Department of Economic and Social 
Affairs, 2015). In order to move towards UHC, one of the things developing countries need to focus on 
is improving access to essential medicines which have remained inaccessible in many Lower and 
Middle-Income Countries (LMICs) for a long time (Pecoul et al., 1999; Bigdeli et al., 2014; United 
Nations Department of Economic and Social Affairs, 2015).  
 
Access to healthcare, including medicine, can be understood using three dimensions; (1) availability, 
(2) affordability and (3) acceptability (McIntyre, Thiede & Birch, 2009; Magadzire et al., 2014). 
Magadzire et al. (2014) and Bigdeli et al. (2014) argue that access [to medicines] is an important element 
that needs to be considered when strengthening health systems particularly the dimension of 
availability. The availability of medicines is critically important in ensuring access to medicines as it 
would be of no use if medicines were affordable and acceptable but not available.  
McIntyre, Thiede & Birch (2009) define availability as a dimension of access to healthcare as the fit 
between the quantity of services and the actual need for those healthcare services. When considering 
the availability of medicines which form a part of healthcare, this definition could be translated as the 
fit between the quantity of medicines on hand and the actual need of the medicines (McIntyre, Thiede 
& Birch, 2009). This definition speaks directly to the absence of medicine stock outs and shortages 
(McIntyre, Thiede & Birch, 2009).  
 
 DEFINITION OF MEDICINE SHORTAGES AND MEDICINE STOCK OUTS 
Many studies that have been carried out on the availability of medicines refer to medicine shortages and 
medicine stock outs as an important challenge (Harries et al., 2007; Barrington et al., 2010, Magadzire 
et al., 2014; Wagenaar et al., 2014; Honda et al., 2015). In the literature reviewed, medicine shortages 
have been defined differently depending on the perspective and context considered (Fox & Tyler, 2003). 
From the perspective of a health organization, medicine shortages may be understood as a problem in 
medicine supply that ultimately affects the way in which the pharmacy will prepare a product to be 
dispensed to a patient or has an influence on the patient care because a prescriber has to choose a 
different medicine for the patient’s treatment (Fox & Tyler, 2003). From the manufacturer’s point of 
view, a shortage refers to the case when the manufacturer is unable to sustain the production of adequate 
quantities of a certain medicine due to unavailability of raw materials or a problem that would have 
occurred during manufacture and as a result they produce medicines which are inadequate to meet the 




Wholesalers consider a medicine shortage a case where they experience any difficulty obtaining a 
medicine from its suppliers (Fox & Tyler, 2003). These suppliers are usually also the manufacturers of 
the medicines (Fox & Tyler, 2003). This definition of a medicine shortage from the wholesaler’s 
perspective does not distinguish between whether the cause of the shortage is due to previous orders 
that were not completely fulfilled by the supplier because the supplier did not have sufficient quantities 
and whether the orders were not fulfilled because the medicines were completely unavailable from their 
supplier at that point in time (Fox & Tyler, 2003). The Stop Stock Outs Group in South Africa have a 
simpler definition for a medicine shortage which encompasses all perspectives and they define it as a 
situation where the stock available is insufficient to satisfy the needs of the clients who need it (Stop 
Stock Outs Group, 2014). Most literature reports on “medicine shortages” as this is a less negative 
phrase compared to “medicine stock outs” however it is evident that a medicine shortage may 
potentially lead to a medicine stock out regardless of whose perspective is considered. In a cross-
sectional survey that explored the experiences of health workers responsible for the provision of 
maternal health care services in Tanzania in relation to drug and supply issues, the nurses reported that 
medicine stock outs occurred after long periods of medicine shortages (Penfold et al., 2013).  
 
Medicine stock outs have been defined as the physical unavailability of a medicine required for patient 
use at the point of care when it is required (Stop Stock Outs Group, 2014). This definition is very similar 
to the definitions of medicine shortages, however the difference between the two definitions is that in 
some cases stock outs may refer to total unavailability of medicines whereas shortages refer to 
insufficient medicines that is medicines are not totally unavailable (Stop Stock Outs Group, 2014). We 
chose to focus on the term ‘medicine stock out’ as it may include both scenarios when medicines are 
available but insufficient to meet patient needs as well as when medicines are totally unavailable). It is 
also clear that both the definitions of medicine shortages and medicine stock outs are similar to that 
used to define the availability of medicines hence many studies that have explored the factors 
influencing the availability of medicines have highlighted the need to reduce the occurrence of stock 
outs and shortages of medicine. In addition to the factors influencing or causing medicine shortages and 
stock outs, studies have also reported on the impact of the unavailability of medicines highlighting the 
need for health systems to make it a priority that they ensure the uninterrupted availability of medicines 




 THE IMPACT/EFFECTS OF MEDICINE SHORTAGES AND STOCK OUTS 
Research has been conducted on medicine availability and shortages used to treat various conditions 
including both communicable and non-communicable diseases (NCDs). Of the studies reviewed in this 
literature review, the studies carried out in the developed world focused on medicines used in treatment 
of cancer and general antibiotics, whilst in Africa the studies reviewed focused mostly on medicines 
used to treat communicable diseases such as HIV/AIDs, TB and malaria which are more prevalent in 
Africa. This shows that medicines availability is an important issue in health systems across the world 
and it does not only affect a specific group of medicines (USAID: Deliver Project, 2011). Some of the 
factors influencing the unavailability of medicines may be specific to that area whilst others may be 
common to both the developing and undeveloped world (Bigdeli et al., 2014).  
 
A survey in various developing countries in 2011 revealed that essential medicines used for chronic 
conditions and those conditions requiring life-long treatment were more prone to stock-outs than those 
used for acute conditions (Cameron et al., 2011; Bigdeli et al., 2014). In the recent years, there has been 
a considerable increase in the prevalence of both communicable and NCDs world-wide (Mayosi et al., 
2009; Magadzire et al., 2014). NCDs have become the leading cause of death as reported by the WHO 
report in 2014. This increase has led to an increased demand for essential medicines used to prevent 
and treat these diseases (Mayosi et al., 2009; Magadzire et al., 2014). The increased demand has placed 
a huge strain on the health sector and this contributed to the shortages and stock outs that occur as 
suppliers fail to meet the increased targets (Mitka, 2011; Magadzire et al., 2014). It is evident that 
availability of medicines used to manage these conditions needs to be improved in order to prevent the 
detrimental effects of stock outs as it has also been predicted that the burden of disease in relation to 
NCDs and communicable diseases such as HIV/AIDS and TB is likely to increase in the coming 
decades (Mayosi et al., 2009; Health Systems Trust, 2015a).  
 
The consequences of medicine unavailability are widespread and can have detrimental effects on 
individuals and public health systems as a whole (Harries et al., 2007; Barrington et al., 2010). An 
important consequence of the unavailability of medicines to governments is the loss of confidence in 
public health systems by citizens which has been reported in studies in Africa (Magadzire et al., 2014; 
Wagenaar et al., 2014; Honda et al., 2015). This is even more detrimental in developing countries as 
most of the population in these countries relies on the public sector for healthcare, for example in South 
Africa 70% of the population relies on the public health sector for health care services (Magadzire et 
al., 2014).  Apart from this loss of confidence, there may also be cost implications to the health systems 




A case study on managing medicine shortages at a hospital in Utah (USA) revealed that shortages of 
medicines resulted in increased or decreased costs to the health facility (Fox & Tyler, 2003). These 
experiences in the USA relate to experiences in the private health sector and they may not be the same 
as in the public sector especially in developing countries (Fox & Tyler, 2003; Cameron et al. 2011). 
This may be due to the fact in developing countries like South Africa, the public sector is tightly 
regulated by the government and it may not be possible for them to incur extra costs without them being 
approved by the government (Cameron et al., 2011). These increase in costs may have resulted from 
similar aspects which have been reported in other studies such as the increase in paid staff time that 
resulted from health workers spending more time at work handling shortages of medicines (Fox & 
Tyler, 2003; Kaakeh et al., 2011). Kaakeh, Sweet et. al (2011) in a study on the impact of drug shortages 
on health systems in the United States of America reported that there was an increase in the overall 
amount of human resources needed in times of drug shortages and this would be even more challenging 
in lower income countries that are facing a human resource crisis (Kaakeh et al., 2011). Pharmacists 
would spend more time managing the shortages and this included trying to source stock from alternative 
suppliers, sending information to other members of the health care team such as prescribers that certain 
medicines are out of stock and updating their data bases with alternative drugs that were available 
(Kaakeh et al., 2011).  
 
Changing to alternative treatments which cost more than the initial treatment and having to order 
alternative pack sizes of medicines which may be more expensive have also been reported as reasons 
for the increased costs to health facilities when they experience medicine shortages or stock outs 
(Mcbride et al., 2013; McKeever, Bloch & Bratic, 2013). Reimbursement from third party payers such 
as health insurance schemes may also prove to be a challenge when shortages occur because these 
payers usually have a set list of medicines that are pre-authorised for treating certain conditions or the 
insurance schemes prefer generic medicines as a means of containing costs. Once these medicines are 
unavailable the health facility may run into problems when they make claims where alternative 
medicines had been used (Fox & Tyler, 2003; Mcbride et al., 2013; McKeever, Bloch & Bratic, 2013). 
This may also translate into increased direct patient costs as the patients may have to pay a levy for 
alternative medicines or treatment that have been substituted due to stock outs or shortages (Mcbride et 
al., 2013).  In the private sector, health professionals may also have a wider choice of medicines that 
they can choose from when their first choices are unavailable as their formularies may be flexible unlike 
in the public sector where the formularies may only include medicines on the essential medicines list 
(Cameron et al. 2011). Any medicines outside the essential medicines list would require authorization 
from higher authorities in the government before the health facilities can order them and use them in 
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place of those medicines which are unavailable at that time (Cameron et al 2011).  This shows us another 
difference in the way medicine stock outs may impact  health facilities in the private and public sectors. 
 
Patients may also incur costs when they need to make alternative plans in order to ensure that treatment 
is not interrupted (Pasquet et al., 2010). These alternative plans may involve patients being referred out 
to other health facilities which may result in added travelling costs incurred as the patients travel to 
alternative facilities including the private sector facilities to source medicines (Pasquet et al., 2010). 
This may become a barrier to accessing medicines and lead to patient treatment being interrupted 
(Magadzire et al., 2014; Harding et al., 2014). To date there is no published research that has studied 
the medicine seeking behaviour of patients as well as the direct cost implications on patients of medicine 
shortages and stock outs however it is also possible that patients may incur opportunity costs as a result 
of medicines stock outs (Magadzire et al., 2014; Harding et al., 2014). These opportunity costs could 
come about as a result of missing paid work to attend health facilities numerous times to check whether 
their medicines are back in stock (Magadzire et al., 2014; Bateman 2013, Stop Stock Outs Group, 2015). 
A common practice in South African health facilities when medicines are unavailable is to give the 
patient a date on which they are to return to the facility to check and collect their medicines if and when 
they are available which translates to additional visits to the health facility (Bateman 2013; Magadzire 
et al., 2014). 
 
Unplanned treatment interruptions could lead to an increase in resistance to antimicrobials and antivirals 
which can have the ripple effect of switching to even more costly treatment and interventions (Harries 
et al., 2007; Pasquet et al., 2010). It may also result in prolonged treatment periods which could 
potentially be even more costly as patients would have developed adverse effects due to not having 
taken their medicines and may need to be hospitalised (McKeever, Bloch & Bratic, 2013). For the 
working population, this would mean loss in time that could have been spent being productive at work 
and would then potentially affect the economy of the country (Mcbride et al., 2013; Ankomah et al., 
2015). Adverse effects such as drug resistance and treatment failure have been documented from 
antiretroviral (ART) clinics in sub-Saharan Africa as consequences of medicine unavailability (Harries 
et al., 2007).  
 
Some of the adverse effects that have been reported in the literature due to medicine shortages and stock 
outs have led to patient deaths (McBride et al., 2013). These deaths occurred as a result of medication 
errors that occurred when changing treatment regimens were changed (Mcbride et al. 2013). There is a 
study where sterile water was unavailable and sepsis occurred in a patient as a result of tap water being 
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substituted to flush feeding tubes before medicines were administered to the patient through the tubes 
(Mcbride et al., 2013; McKeever, Bloch & Bratic, 2013). Such medicine errors may occur where the 
health workers are less familiar with the alternative medicines, for example how they need to be mixed, 
dosages and directions of use and there is inadequate time to train them on this as the medicine shortage 
would have occurred unexpectedly (Mcbride et al., 2013). When a patient receives alternative treatment, 
there is a possibility of having a reaction or side effects that were not present on the previous usual 
treatment and this too is considered an adverse effect that would have resulted from medicine shortages 
and stock outs in the literature (McKeever, Bloch & Bratic, 2013; Mcbride et al., 2013; Ankomah et al., 
2015).  
 
 The effect of medicine unavailability impacts many aspects of the healthcare industry including 
research and development of new medicines that could benefit the public as it has been reported that 
clinical trials especially for oncology treatment have been halted due to shortages in supply of medicines 
or raw materials used to manufacture the medicines. (Mcbride et al., 2013). In oncology, there is often 
very limited knowledge on treatment alternatives which themselves are limited and for this reason it 
has been argued that some medicine shortages are more life-threatening than others in as much as the 
goal is to ensure that all medicines are always available (Mcbride et al., 2013). Medicine shortages and 
stock outs of some medicines have been argued to be more serious than others even though the goal of 
health facilities is to ensure that they never occur (Cameron et al., 2011; Mcbride et al., 2013).  
 
 CAUSES OF MEDICINE SHORTAGES AND STOCK OUTS  
In order to address the challenges of medicine stock outs and shortages there has been some research 
carried on the subject and the literature reports various causes of medicine stock-outs and shortages 
which seem to be more pertinent in the lower income countries and smaller public health facilities such 
as clinics (Schouten et al., 2011; Bateman, 2013; Wagenaar et al., 2014). The causes are linked to 
problems embedded in the pharmaceutical procurement and distribution systems (Pecoul et al., 1999; 
Bateman, 2013).  
 
For a healthcare system to function well it is very important for the medicines supply system to be one 
that is efficient (World Health Organisation, 2017). It is also important to note that, due to the 
complexity of health systems, external factors may affect other elements of the health system which, in 
turn, influence the supply of medicine.  Such factors include the lack of human resources, lack of 
finances that are sustainable, information systems that are not comprehensive, these are cited by the 
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WHO as essential components of ensuring that the supply of medicines is uninterrupted.  It is thus very 
important to continually asses and improve medicine supply systems to ensure uninterrupted access to 
medicines (Lufesi, Andrew & Aursnes, 2007). The more complex the medicines supply chain is, the 
more likely that it will be inefficient and medicine stock outs will occur (Hensen et al., 2011) 
 MEDICINES SUPPLY SYSTEMS/CHAINS 
The medicine supply chain consists of the selection, procurement, storage, shipping and ultimately 
distribution of medicines (World Health Organisation, 2017). Any weakness along this chain can 
potentially lead to stock outs and shortages (Berger et al., 2007; Lufesi, Andrew & Aursnes, 2007; 
Harries et al., 2007; Schouten et al., 2011; World Health Organisation, 2017). Factors along this supply 
chain that are associated with stock-outs and shortages reported in the literature include, manufacturing 
shortfalls, errors in ordering, delayed or changing procurement strategies, difficulties in transporting, 
sudden increases in demand for products, inadequate funding and staffing as well as exploitation of 
national goods (Ketikidis et al., 2006; Berger et al., 2007; Harries et al., 2007; Schouten et al., 2011; 
Bateman, 2013; Hasselback et al., 2014; Wagenaar et al., 2014; Stop Stock Outs Group, 2015).  
 
 PROCUREMENT AND SELECTION 
It is recommended that the selection and procurement of medicines in countries and health facilities be 
based on an Essential Medicines List (EML) in order to ensure that the most basic medicines are 
available for use by the population (World Health Organisation, 2017). The WHO encourages that this 
list be reviewed by Pharmaceutics and Therapeutics Committees (PTCs) to ensure that the medicines 
included on the list are those that will satisfy the needs of most of the population (World Health 
Organisation, 2017). In many countries, a standard EML will exist and can be used by health facilities 
to draw up their own list which they would have personalised according to the health needs of the 
population they serve.  
The methods used for procurement differ from country to country. Procurement includes the ways in 
which suppliers of the selected medicines are chosen (World Health Organisation, 2017). It is essential 
for health systems to have a set method or system for selecting suppliers which would include how the 
suppliers are pre-qualified, the establishment of the contract terms between the health system providers 




Open tender systems are widely used to procure medicines as they may be beneficial in terms of costs 
however it is advised that they be avoided or considered together with other strategies because them 
may result in unforeseen delays that governments have little control over (Kangwana et al., 2009). The 
prices of medicines may influence the procurement and selection phase of the supply chain as health 
systems endeavour to make cost-effective decisions as well as to make sure that the medicines remain 
affordable to the end user especially in the cases where the patients have to pay for their own medicines 
(Kangwana et al., 2009).  
 
Health financing, also considered one of the elements of the health system has a role to play in the 
supply of medicines and it is vital for the source of funds that is used to pay for medicines needs to be 
one that is reliable and sustainable (Pasquet et al., 2010). The reliance of programmes such as malaria 
programmes on donor funding to purchase medicines can be problematic as this funding is not always 
a reliable and sustainable source of revenue (Pasquet et al., 2010; Mikkelsen-Lopez et al., 2014). Where 
governments are not prepared for cases of donors withdrawing funds, stock outs have occurred and it 
is advised that governments ensure that buffer stock is always available especially for essential 
medicines for such unforeseen circumstances (Harries et al., 2007; Pasquet et al., 2010; Mikkelsen-
Lopez et al., 2014).  To ensure that medicine shortages do not occur, accurate quantification of the 
required medicines is needed and this should be based on past consumption data as well as using the 
right procurement methods which may be a mix of more than one method (World Health Organisation, 
2017). 
 
 FORESCASTING  
Forecasting in medicine supply systems refers to the techniques that are used to ensure that a facility 
has enough stock to meet the potential demand for those particular medicines in a specified period of 
time (USAID: Deliver Project, 2011). If a structured system for forecasting exists, the occurrence of 
stock outs and shortages is likely to be reduced (Harries et al., 2007).  It has been reported that in many 
cases it is the methods used to forecast or lack thereof by facilities that results in medicine shortages 
and stock outs occurring  (Lufesi, Andrew & Aursnes, 2007; Bigdeli et al., 2014). The Practical Guide 
for the Supply Chain Management of Health Commodities recommends that the methods used when 
forecasting be based on past consumption data reflecting on the burden of disease in the area however 
this data must be reviewed from time to time as some diseases may be seasonal (USAID: Deliver 
Project, 2011). The constant reviewing of consumption data would ensure that the quantities ordered 




In order to store consumption data over long periods of time, it was found in a study on scaling up ART 
by Barrington, Wereko-Brobby et al (2010) to be beneficial for the health facility to have a good 
information system in place. The facilities that did not have information systems that were computerized 
struggled with forecasting accurately for the patients who needed ART and thus experienced shortages 
more often (Barrington et al., 2010). Information systems refer to the technologies that may be utilised 
by health facility staff when managing the levels of medicine stock as well as sharing of information 
related to medicine stock management (Barrington et al., 2010; USAID: Deliver Project, 2011). These 
may be electronic or paper based which require different levels of skill and expertise to use them well 
(USAID: Deliver Project, 2011).  
 
Non-existent or poor stock control including poor forecasting are the major causes of stock outs and 
shortages reported in literature at the health facility level when stock is available at the central or depot 
level (Barrington et al., 2010). In a study by Lufesi et. al (2007) in Malawi, some discrepancies were 
found between the reported stock levels and actual stock on hand at health facilities implying that the 
health workers were not following protocols on the medicine stock management. It was suggested that 
this non-compliance could have been because of lack of training and supervision from seniors such as 
district pharmacists (Lufesi, Andrew & Aursnes, 2007). The management of medicines supply is 
essential for the provision of health care and even more important in lower income countries where 
resources are scarce as it has also been reported that one of the major areas of wastage in the health 
system occurs in the use of medicines (World Health Organization, 2010; Schouten et al., 2011) 
 
 STORAGE OF MEDICINES 
Storage in medicine supply systems involves ensuring that the medicines are kept safely and not 
damaged and this could be at any point in the medicine supply cycle (USAID: Deliver Project, 2011; 
World Health Organisation, 2017). If medicines are damaged or stolen, this could result in medicine 
shortages or stock outs occurring at the health facilities as damaged medicines would not be suitable 
for use (Lufesi, Andrew & Aursnes, 2007).  
 
It is very important that medicines are stored in adequate quantities in order to ensure that the facilities 
are able to meet the demand and it has been recommended that health facilities also keep “buffer stock” 
also referred to as “safety stock” at all times as this is one way of preventing medicine shortages (World 
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Health Organization, 2010; Schouten et al., 2011). In some cases, the health workers at facilities are 
unable to comply with the recommended guidelines for ordering stock in terms of ordering sufficient 
quantities of medicines because the capacity of the health facilities themselves is insufficient (World 
Health Organization, 2010; Schouten et al., 2011).  Bulk storage areas would be ideal for keeping this 
excess stock however the infrastructure at some facilities may not allow for this (Schouten et al., 2011). 
  
 
 DISTRIBUTION OF MEDICINES 
Distribution of medicines refers to the flow of medicines from the warehouse or central store which is 
the higher level that is responsible for supplying medicines to the facilities where they will be ultimately 
dispensed to patients (USAID: Deliver Project, 2011). This would include the systems used by the 
health facilities to order their medicines as well as the transportation of the medicines from the central 
store to the health facilities (World Health Organisation, 2017). There are two main types of distribution 
systems which are the push and the pull systems and these can be differentiated by who decides on the 
quantity of stock to be supplied to the health facility (USAID: Deliver Project, 2011).  
 
The push system also referred to as the ‘‘allocation’’ systems in some literature is whereby the medicine 
stock is pushed from the higher-level facility such as the central store and they decide on the quantities 
to be supplied to the lower level facilities i.e. the health facilities such as clinics or hospitals (USAID: 
Deliver Project, 2011; World Health Organisation, 2017). This means that the higher level would need 
to calculate quantities for orders from all the facilities and this would be challenging in the larger health 
systems as it is time consuming (USAID: Deliver Project, 2011). This system is mostly used when new 
programmes are being initiated or when donors supply stock to health facilities at the lower levels and 
it does not always take into consideration consumption data on the products supplied (World Health 
Organisation, 2017). The reasons why consumption data may not be used in deciding on the quantities 
could be because it is unavailable for example if it is a new program it may not be known how many 
people will require that medicine if no prior research has been done (World Health Organisation, 2017). 
It has been reported in the literature especially in the lower income countries that there may not always 
be information systems that link the lower level to the higher level facilities allowing both levels to 
view the amount of stock available at the facilities (Harries et al., 2007; Barrington et al., 2010; 
Schouten et al., 2011; Githinji et al., 2013). This information on stock levels would particularly be 
useful where the push systems are utilised more than the pull systems as the higher level could then 
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come up with more accurate quantities of stock to supply to the lower level facilities (USAID: Deliver 
Project, 2011).  
 
As it is advisable to base quantities for re-supply on consumption data and current stock levels, it may 
be argued that the pull system also known as the ‘requisition’ system would be a much better one to use 
as the lower level facility is the one that decides on the quantity of medicine to be supplied to them 
(USAID: Deliver Project, 2011). However, this would imply that the health workers at the lower level 
facilities are skilled and have the time to carry out the necessary calculations to derive the most accurate 
quantities and it is well known that the health workforce is currently facing a human resource crisis 
with not enough health workers to serve the populations and this is particularly a problem in the lower 
income countries (Hongoro & McPake, 2004; USAID: Deliver Project, 2011; World Health 
Organisation, 2017). In order to bypass the weaknesses and benefit from the strengths in both systems, 
most health systems use a mix of these systems (Barrington et al., 2010; USAID: Deliver Project, 2011).  
 
Transportation of medicines would also be considered as part of the distribution of medicines and it has 
been reported that this too may influence the occurrence of medicine shortages as well (World Health 
Organisation, 2017). In some countries, the health facility itself is responsible for arranging for the 
transportation of medicines to the facility and this may be a challenge for health facilities that do not 
have sufficient resources such as drivers and vehicles to collect the medicines from the central store 
(Hasselback et al., 2014; World Health Organisation, 2017). In these cases, it may be beneficial if the 
central warehouse transports medicines to the facilities as it is done in other countries however this too 
may come with challenges which are inevitable due to the inaccessibility of health facilities (Hasselback 
et al., 2014). 
 
It has been reported that medicine stock outs and shortages are worse in rural areas where there may be 
transportation and accessibility challenges (Bateman, 2013; Hasselback et al., 2014). A study in 
Mozambique reported that the further away facilities were from the depots, stock outs occurred more 
frequently (Hasselback et.al. 2014). This may have been due to difficulties faced by the depots in 
transporting medicines and accessing the health facilities by road in the more rural areas (Lufesi, 




 OTHER GENERAL CAUSES OF MEDICINE SHORTAGES AND STOCK OUTS 
Ensuring medicines availability is an important goal for health systems as medicines are an important 
building block in the health system (Bigdeli et al., 2014). Some of the factors influencing the occurrence 
of stock outs at the health facility level stem from the way in which medicine stock is managed at health 
facilities and could be as a result of the inventory control methods used, information and reporting 
systems used, capacity of the health facilities as well as health workers and communication between 
key actors in the processes (Harries et al., 2007; Lufesi, Andrew & Aursnes, 2007; Barrington et al., 
2010; Githinji et al., 2013).  
 
Literature suggests that information systems may also facilitate efficient communication between 
various stakeholders involved in the processes of medicine stock management (Githinji et al., 2013).  
Communication refers to the sharing of information and in the case of medicine stock management, this 
information relates to medicine stock (Barrington et al., 2007). The information shared between a health 
facility and the supplier of medicines may include the medicines available for order such that when 
placing an order, the health facility may make an informed decision on which medicines and quantities 
of medicines to be ordered for the facility (USAID: Deliver Project, 2011). When the supplier fulfils an 
order, it would also be beneficial for them to have access to information on what stock is available at 
the health facility so that they too can make an informed decision on how much to supply them with 
(USAID: Deliver Project, 2011). This sharing of information on stock levels would eliminate possible 
cases of stock outs occurring due to stock being under-supplied to the facility (USAID: Deliver Project, 
2011). Studies found that where communication between stake holders involved in medicine stock 
management was efficient, less stock outs occurred (Berger et al., 2007). Strategies to mitigate medicine 
stock outs in various countries have been moving away from the conventional paper based methods of 
communication to include on-line and electronic information sharing systems which allow access to 
real-time information (Berger et al., 2007; Barrington et al., 2010). 
 
Communication with other stakeholders as well as the use of information systems which may be 
electronic may be related to the capacity of the health workers required to use these information systems 
(Lufesi, Andrew & Aursnes, 2007). These systems may require certain skills for example if the system 
is computer based, the ability to use a computer would be essential (USAID: Deliver Project, 2011). 
The capacity of health workers refers to the extent to which the health workers are qualified and able to 
manage medicine stock which would include using the resources available to them (Lufesi, Andrew & 
Aursnes, 2007). The health facility itself, in some cases may limit the health workers if it does not have 
adequate resources (Lufesi, Andrew & Aursnes, 2007). This speaks to the capacity of the health facility 
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and includes having adequate human resources as much as physical resources required for the 
management of medicine stock (Lufesi, Andrew & Aursnes, 2007).  
 
In the medicine stock management at the clinic level, contextual factors which may influence the 
process include the geographic location of the clinic, the district as well as provincial management 
teams, and the disease burden in the district or area served by the clinic (Lufesi, Andrew & Aursnes, 
2007; USAID: Deliver Project, 2011; Hasselback et al., 2014). Contextual factors may also influence 
the actors affecting the way they carry out their roles. These actors include the district pharmacists and 
the provincial head of pharmaceutical services.  
 
The geographic location of health facilities may influence medicine stock management in several ways 
(Hasselback et al., 2014). The location may affect the communication processes between actors and the 
delivery of medicines from the pharmaceutical depot. It has been reported that medicine stock outs and 
shortages are worse in rural areas where there may be transportation and accessibility challenges 
(Bateman, 2013; Hasselback et al., 2014). A study in Mozambique by Hasselback et. al (2014) reported 
that the further away facilities were from the depots, stock outs occurred more frequently. This may 
have been due to difficulties faced by the depots in transporting medicines and accessing the health 
facilities by road in the more rural areas (Lufesi, Andrew & Aursnes, 2007).  
 
The geographic location may also have an influence on the health workers that are employed at the 
facilities. Studies have found that health workers are motivated to work in urban rather than rural areas 
therefore the calibre and capacity of workers found in a health facility may be influenced by the context 
in which the facility is found (Lufesi, Andrew & Aursnes, 2007). The capacity of the health workers in 
that region which in-turn influences their ability to follow protocols in inventory control and their ability 
to use information and reporting systems (Lufesi, Andrew & Aursnes, 2007). facilities by road in the 
more rural areas (Lufesi, Andrew & Aursnes, 2007).  
 
The causes of medicine stock outs as we have seen can be at various levels within the supply chain even 
though the impact of stock outs is mostly crucial at the health facility level (Bateman, 2013; Hensen et 
al., 2011). As the pharmaceutical supply chain is a complex process, there may also be many inter-
linkages (Hensen et al., 2011). When addresses the causes of medicine stock outs, it is vital for policy 
makers to address those causes specific to health facilities such as hospitals and clinics as it would be 
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of no use if medicines were available from manufacturers as well as warehouses but there were factors 
at the health facility level which resulted in inefficient medicines supply (Hensen et al., 2011).  
 
 
 STRATEGIES TO ENSURE UNINTERRUPTED AVAILABILITY OF MEDICINES 
Studies have reported different ways of handling medicine stock in case where there are known 
shortages in order for it to last longer and it has been acknowledged that in order to handle medicine 
shortages well, healthcare providers need to ensure that they have systematic processes of how to handle 
shortages and these ways can be in the form of standard operating guidelines or procedures (Kaur et al., 
2013; McKeever, Bloch & Bratic, 2013).  Just like other resources in healthcare facilities, the rational 
use of medicines is advised regardless of whether there is a chance that stock outs of that particular 
medicine may occur. However, when stock is limited, it is even more important to ensure that the limited 
stock available is utilised in the best possible way and this is commonly referred to as rationing (USAID: 
Deliver Project, 2011). Rationing of medicine stock may be initiated at the higher level facilities such 
as the medicine store when they are aware of the medicine shortage or at the lower level health facilities 
when they have insufficient stock to provide to all their patients (USAID: Deliver Project, 2011; Kaur 
et al., 2013).  
 
A case study on a hospital in Massachusetts’s response to a global shortage of amino acids revealed that 
when the health workers were aware of the shortages, they began to use the available stock of amino 
acids sparingly when preparing total parenteral nutrition (TPN) (Kaur et al., 2013). The hospital also 
then limited the number of people who were handling orders for TPN to the clinical pharmacist and 
dietician to ensure that there are people who can be held accountable for managing the stock and 
ensuring that the patients who needed TPN the most were able to get it (Kaur et al., 2013). This case 
study allowed in-depth exploration of what measures the hospital took and even though the study was 
only carried out in one place, its findings are recommendable to health facilities (Kaur et al., 2013). 
Another study on drug shortages in cancer treatment suggests prioritization of patients when there are 
shortages which can also be considered as rational use of the available resources (McKeever, Bloch & 
Bratic, 2013). It is recommended that a list of criteria be drawn up considering various things that will 
enable an independent committee to choose which patients should receive the treatment when it is not 




As technology advances in Africa, some countries have taken advantage of this and upgraded their 
medicine management systems from paper based to computer and web-based systems as a measure of 
mitigating medicines unavailability (Berger et al., 2007; Githinji et al., 2013). The successful 
implementation of web-based systems has solved the problem in Haiti where obstacles existed with the 
paper based systems (Berger et al., 2007). This system facilitated communication which is vital for the 
management of stock levels between stakeholders involved in the processes (Berger et al., 2007). In 
South Africa, a software programme, Rx solution® has been introduced in some public health facilities 
to support the regulation of stock control in public health facilities (Health Systems Trust, 2015b; 
Management Science for Health, 2016, July 16). This programme allows the monitoring, tracking, and 
ordering of medicine stock as well as movement of stock among health facilities on a computer 
(Management Science for Health, 2016). Inventory control systems that are well established will help 
health facilities to ensure that stock outs do not occur as the system will inform them when to order and 
what quantities to order (USAID: Deliver Project, 2011). The major advantage of these computer based 
systems is that they are able to generate re-order quantities for the health workers relieving them of the 
task of doing this for themselves manually (USAID: Deliver Project, 2011). It is also important for these 
systems to be linked to the higher levels so that the information on medicines availability is available 
to all the stakeholders involved in the processes of medicine stock management (USAID: Deliver 
Project, 2011).  
 
There have been some strategies that have been employed in order to improve the reporting of medicine 
availability by lower level facilities to the higher-level facilities who supply them with stock. In Kenya, 
an SMS for life was implemented for anti-malarial medicines and it also solved the problems of 
unavailability of rapid diagnostic tests and anti-malarial medicines by enhancing stock visibility 
(Githinji et al., 2013). With this system, health workers at clinics used their personal cell phone devices 
to send the weekly facility stock levels via SMS to a central data base which was accessible to those at 
the higher level such as the district managers (Githinji et al., 2013). The study found that this 
intervention improved the rate of reporting of the clinics and as a result the district managers could 
intervene on medicine shortages once identified on the central database by arranging that clinics which 
had more stock than they needed shared it with those with a shortage and this reduced the occurrence 
of stock outs (Githinji et al., 2013). This SMS for life project is similar to the Stock Visibility Solution 
(SVS) that has been implemented in 3126 clinics in South Africa by July 2015 also with the hope of 
improving the reporting of medicine stock levels in a bid to reduce stock outs (Chowles, 2016, July 15). 
 
SVS also uses cell phones to scan barcodes of medicines that rare available at the health facility and 
will generate alerts when stock is too high or too low to both the health facility and those with access 
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to the central database where the information is loaded such as the district managers (Chowles, 2016, 
July 15). As the programme has only been recently implemented, there has not yet been any published 
research on how effective it has been in improving the availability of medicines. Another programme 
that has been implemented in South Africa to address the issues of drug stock outs particularly for 
chronic diseases is the Central Chronic Medicine Dispensing and Distribution Programme (CCMDD) 
(Health Systems Trust, 2015a). The aim of this programme was to reduce the burden on PHC clinics 
and increase the availability of medicines for chronic conditions which are becoming more prevalent in 
South Africa (Health Systems Trust, 2015a).  
 
 DRUG SUPPLY MANAGEMENT AT HEALTH FACILITIES AND MEDICINES AVAILABILITY 
Medicines supply management in health systems occurs at more than one level and the factors that 
influence this at the health facility level may not always stem from the health facility itself. However, 
studies have reported that some health facilities may have medicine shortages even though the stock is 
available at the central level which supplies them with medicines. There is a lack of research that has 
been carried out at health facility levels such as PHC clinics exploring the processes at the facility and 
how these may be linked to the occurrence of medicine stock outs levels especially in the lower income 
settings (Hasselback et al., 2014). The absence of medicines stock outs at these levels should be 
prioritised in many countries like South Africa where the majority of the population relies on the public 
sector for health services, these PHC clinics are usually the entry point for citizens into the healthcare 
system (Bigdeli et al., 2014).  
 
The factors that contribute the most to the occurrence of stock outs of medicines at the facility level 
include inadequate health workforce particularly pharmacy personnel, poor medicine stock 
management, and inefficient communication between suppliers, depots and health facilities (Bateman, 
2013). The inefficient communication between actors involved in medicine supply at the facilities is 
also a problem that has been reported (Bateman, 2013; Stop Stock Outs Group, 2015).  
 
 OVERVIEW OF THE AVAILABILITY OF MEDICINES IN SOUTH AFRICA  
The health system in South Africa like many other developing countries, consists of two sectors which 
are the private health sector and the public health care sector. The public health care sector in South 
Africa is administered by the South African government as it is state funded and it caters for 
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approximately 70% of the country’s population (McIntyre et al., 2009; Public Service Commission, 
2015). The public sector therefore carries the major burden of disease which in turn largely consists of 
the management and treatment of HIV and TB (Stop Stock Outs Group, 2015). Within the public health 
system, PHC clinics are the foundation and entry point of many into the health care system ((Bigdeli et 
al., 2014; Public Service Commission, 2015). For treatment that is more sophisticated, patients are 
referred to district hospitals. Above the district hospital, tertiary and academic hospitals provide 
advanced health care procedures and treatment (Public Service Commission, 2015). As the PHC clinics 
are the entry point into the health system, it goes without saying that they need to be made a priority 
within the health system as in some cases, if patients are satisfactorily treated at this level, they will not 
require more advanced treatment at the hospital level.  
Section 27 of the South African constitution states that citizens have the right to access health care 
therefore it is essential to consider aspects such as the availability of medicines that have a direct impact 
on access to health care (Stop Stock Outs Group, 2015).  In South Africa, surveys have revealed the 
extent of drug stock outs and perceived causes of stock outs by health workers (Stop Stock Outs Group, 
2014; Stop Stock Outs Group, 2015; Public Service Commission, 2015). From these reports, it is 
suggested that one of the reasons why essential medicine stock outs and shortages occur at the PHC 
level is because of the fore-casting and poor medicine stock management by health workers at the clinics 
(Stop Stock Outs Group, 2015).  
The factors that contribute the most to the occurrence of stock outs of medicines in South Africa include 
an inadequate health workforce particularly pharmacy personnel, poor medicine stock management, 
and inefficient communication between suppliers, depots and health facilities (Bateman, 2013). The 
inefficient communication between the depot and health facilities is a problem because in some cases 
the clinics do not warn the depot well in advance that they will require larger quantities of stock than 
the usual quantity and thus the depot is unprepared and unable to meet their needs (Bateman, 2013; 
Stop Stock Outs Group, 2015). Each public health facility including the PHC clinics are required to 
sign a ‘terms of agreement’ contract with the pharmaceutical depot which outlines the way in which the 
two parties interact in terms of the ordering and supply of medicines(Bateman, 2013). The 
pharmaceutical depot, located in each of the nine provinces in South Africa is responsible for supplying 
medicines to all the public health facilities in that province (Bateman, 2013). However, the interactions 
between the depot and health facilities does not always follow the recommendations made in this 
contract and this negatively affects medicine stock management at the facilities and leads to stock outs 
of medicines (Bateman, 2013). 
In light of the evidence of poor medicine stock management of essential medicines in the public health 
facilities and frequent problems of drug stock-outs or shortages in South Africa, the search for an 
effective management system is a priority for the current government (Public Service Commission, 
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2015). A Discrete Choice Experiment on improving the public health sector in South Africa also 
revealed that the availability of medicines at health facilities has the greatest impact in the probability 
that people will attend public health facilities (Honda et al., 2015). South Africa is moving towards 
implementing the National Health Insurance (NHI) in the coming years as a bid to move towards 
achieving UHC. The white paper released mentions the need to address the quality of healthcare of 
which availability of medicines is one of the areas that need attention. Access to medicine needs to be 
improved especially in the Primary Health Care (PHC) clinics which are usually the entry point for 
citizens into the healthcare system for successful implementation of the NHI. 
 METHODS USED IN RESEARCH ON MEDICINE STOCK OUTS 
Of all the articles that were reviewed, one was a systematic literature review and it focused on assessing 
the evidence to which health care providers, particularly clinicians changed the ways in which they 
prescribed medicines when certain medicines were out of stock (Hensen et al., 2011). This is one of the 
commonly cited impacts of medicine shortages and stock outs to the health care worker. There were no 
other systematic reviews on medicine shortages and stock outs or the factors influencing them which is 
a disadvantage since systematic reviews are rich sources of literature in that they combine findings from 
more than one study on a particular subject Green & Thorogood, 2014). From the literature searches 
conducted, there was a lack of theoretical frameworks that could be used in this study hence the 
literature review included mostly empirical evidence.  
 Most of the studies in the literature reviewed employed mixed methods to answer their research 
questions and this is advantageous as a way of increasing rigour Green & Thorogood, 2014). Validating 
responses can be done by using mixed methods, for example using qualitative methods in order to come 
up with the questionnaires or the use of focus group discussions (FGDs) in addition to quantitative 
methods (de Bekker-Grob, Ryan & Gerard, 2012). The causes of medicines availability are best 
described in a qualitative way therefore it makes sense that most of the studies had a qualitative 
component in them. Qualitative studies allow for in-depth analyses of phenomena in research which is 
beneficial when trying to determine the causes of medicines unavailability.  
Some of the articles were cross sectional surveys and these have been critiqued for their lack of ability 
to analyse trends that take place over time which may be useful when considering the causes of 
medicines unavailability (Green & Thorogood, 2014). This is because these factors are often complex 
and may not occur at one specific point in time. Another short-coming is that some of the impacts of 
medicines unavailability may be felt after a long period of time long after the shortage occurred for 
example. However, cross-sectional studies are still useful and suitable when considering issues in 
availability of medicines such as the extent of medicines shortages as this can be measured in a specific 
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period (Green & Thorogood, 2014). They also allow for the exploration of aspects which may lead to 
further research (Green & Thorogood, 2014). Table 1 summarises the articles reviewed. 
 
Conclusion  
A considerable amount of research has been conducted in the area of medicines availability particularly 
to determine what the likely causes of unavailability are. It is known that the causes of medicines 
unavailability are mostly embedded in the medicine supply systems, particularly in the procurement 
and distribution of medicines (Pecoul et al., 1999; Bateman, 2013). The complexity of the processes 
involved and the involvement of many stakeholders has been reported as having a major influence on 
the occurrence of medicine shortages and stock outs resulting in medicines being unavailable for patient 
use (Lufesi, Andrew & Aursnes, 2007. Whilst a lot of the research conducted has focused on the factors 
that may influence the availability of medicine on a larger scale or at higher levels in the medicines 
supply chain such as wholesalers and manufacturers, few studies have focused on the lower levels were 
medicines are physically dispensed to the patient. Non-existent or poor stock control including poor 
forecasting are the major causes of stock outs and shortages reported in literature at the health facility 
level when stock is available at the central or depot level and it is very important to continually asses 
and improve medicine stock management at the health facility level to ensure uninterrupted access to 
medicines for patients that visit these facilities (Lufesi, Andrew & Aursnes, 2007. This study aims to 
examine the processes in medicine stock management at PHC facilities to better understand the causes 










Table 1: Summary of Articles 
Author Methods Study Focus and country 
1. Ankomah, J. 
et al, (2015) 
Mixed methods, qualitative and 
quantitative aspects, a strength of this 
study was that it used different sources of 
data which were triangulated and this 
increases rigor. 
The causes of unavailability of 
products in Ghana. 
2. Barrington, J 
et al. (2010) 
Pilot study; cross-sectional, mixed 
methods. 
Drug supply management using 
standard technology in Tanzania. 
3. Berger E.J. Et 
al. (2007) 
Qualitative, descriptive.  Implementation and evaluation of a 
web based system for pharmacy 
stock management in rural Haiti. 
4. Fox, E.R and 
Tyler, L.S 
(2003) 
Qualitative and descriptive study Tracking drug shortages and causes 
in the USA.  
5. Githinji, S. et 
al. (2013) 
Cross-sectional evaluation, mixed 
methods. 
This study evaluated whether the 
SMS based reporting of stock of 
antimalarial diagnostic tests and 
medicines resulted in a reduction of 
stock outs in Kenya. 
6. Harding, R. 
eta al. (2014) 
Cross sectional quantitative survey. Used 
onsite verification via unannounced 
visits-strength of methods; reliability of 
data. 
Availability of essential drugs for 
managing HIV-related pain and 
symptoms in Kenya and Uganda.  
7. Harries, et al. 
(2007) 
Descriptive, case study. Improving procurement and 
distribution practices of medicines 
in Malawi.  
8. Hasselback, 
L. et al. 
(2014) 
Cross-sectional survey, mixed methods; 
case study with quantitative aspects. 
Causes of stock outs of Malaria 
diagnostic tests in Mozambique.  
9. Henson, B. et 
al.  (2011) 
Systematic literature review The aim of this review was to assess 
the evidence on the extent to which 
prescribing patterns of providers for 
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malaria patients differed in the 
presence and absence of stock. 
10. Kaakeh, R., 
(2011) 
Online survey for pharmacists. One 
weakness is that it used retrospective data 
based on recall of the participants. 
 Impact of drug shortages and 
quantifying human resources 
required to manage shortages in the 
USA. 
11. Kangwana, 
B.B., et al. 
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Cross-sectional survey. Mixed methods. Malaria drug shortages in Kenya as 
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for life threatening diseases in 
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13. Mcbride, A. 
et al. (2013) 




A.E. et al. 
(2013) 
Report  Impact of drug shortages in cancer 
patients in the USA.  
15. Mikkelsen-
Lopez, I. et al 
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Cross-sectional, quantitative The challenge to avoid anti-malarial 
medicine stock-outs in an era of 
funding partners in Tanzania 




Mixed methods  Medication supply chain 
management through 
implementation of a hospital 
pharmacy computerized inventory 
program in Haiti.  
17. Pasquet, A., 
et al.  (2010) 
Quantitative cohort study. Frequency and impact of stock outs 
of cART in Cote D’Ivoire.  
18. Jatau B, et al. 
(2015) 
Cross-sectional evaluation, descriptive Evaluation of Procurement and 
Supply Management System for 




E.J., et al. 
(2011) 
Report Antiretroviral drug supply 
challenges in the era of scaling up 
ART in Malawi.  
20. Muhamadi L, 
et al. (2011) 
Case control Causes of late ART initiation in 
Uganda. 
21. Dorsey ER, et 
al. (2009) 
Quantitative Selegiline Causes and costs of a 
generic drug (Selegiline) shortage in 
the USA.  
22. Griffith MM, 
et al.  
(2013) 
Review article Managing antimicrobial drug 
shortages in hospitals in the USA. 
23. Windisch R. 
et al. (2011) 
Mixed methods, largely qualitative used 
grounded theory approach, triangulation 
of data. 
Supply chain management of ART 
in Uganda and its relation to health 
systems 
24. Mitka, M. 
(2011)  
Report FDA, US hospital and pharmacy 
groups report drug shortages a 
growing problem. 
25. McLaughlin 
MM, et al.  
Observational, cross-sectional Projections for anti-infective drug 
shortages and time to actual 
resolution in the USA. 
26. Mayimele N 
et al. 2015 
Qualitative, exploratory and descriptive The role of pharmacists in medicine 
management at hospital ward level 
in South Africa. 
27. Penfold S, et 
al. 2013  
Mixed methods, cross-sectional survey 
used Focus Group Discussions (FGDs) 
and in-depth Interviews (IDIs) with heath 
workers. Member-checking used to 
increase rigour. 
Staff experiences on the impact of 
equipment and drug supply issues 
on the provision of maternity 
services in rural southern Tanzania. 
28. Magadzire, 
B.P. et al. 
2014 
Cross-sectional, qualitative study, semi-
structured interviews.  
The perceptions of health workers 
on how to improve access to 
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The unavailability of medicines due to stock outs is a barrier to accessing essential medicines. Essential 
medicines most prone to stock outs include chronic medicines and those used to manage communicable 
diseases such as HIV and TB.  A qualitative multiple case study approach was used to examine actual 
practice on medicine stock management at four PHC facilities in a South Africa province which 
reported the largest proportion of stock outs of ARVs and TB medicines in 2015 and 2016. Semi-
structured interviews were conducted with health workers identified as stake holders in medicine stock 
management. Questions were guided by themes developed in a conceptual framework from a literature 
review. Data from these interviews, observations and document reviews was analysed using a multiple 
coding process to identify common themes in the cases followed by a cross case analysis in NVivo. The 
main factors influencing the occurrence of medicine stock outs included medicine stock levels not being 
kept up to date at the facilities and not using the recommended methods of forecasting when placing 
medicine orders from the pharmaceutical depot. This may have been due to lack of capacity in terms of 
physical resources as well as human resources both at the PHC facilities and at the district level from 
which oversight and support of medicine stock management should have come from. Other challenges 
faced by health workers at the PHC facilities include insufficient information systems which affected 
their communication between stake holders. Many studies have focused on the factors that influence 
medicine availability at the higher levels this study focused on what may influence it on the ground, the 
PHC facility level. Future research could be conducted on using mobile health technologies in medicine 






The unavailability of essential medicines at health facilities is a major barrier to accessing medicines in 
many Low and Middle-Income Countries (LMICs) particularly at smaller public health facilities such 
as clinics in rural areas (Schouten et al., 2011; Wagenaar et al., 2014). In southern Africa, household 
surveys estimated that approximately 20% of patient visits to public health facilities end with patients 
unable to receive medicines (Wagenaar et al., 2014). As many countries move towards achieving 
Universal Health Coverage (UHC), the issue of medicine availability continues to require attention 
(United Nations Department of Economic and Social Affairs, 2015). Thus, there has been a considerable 
amount of research done to find out what causes the unavailability of medicines. 
 
Medicine stock outs and shortages are defined as situations where medicines are physically unavailable 
or insufficient for patient use when required (Stop Stock Outs Group, 2014).  They may result from 
manufacturing shortfalls stemming from raw material shortages, sudden increases in demand for 
products due to epidemics, issues related to the production and regulation of medicines as well as the 
complex pharmaceutical procurement and distribution systems (Fox & Tyler, 2003; Harries et al., 2007; 
Bateman, 2013; Wagenaar et al., 2014). At the health facility level, the major causes of medicine 
unavailability when it is available from the supplier lie in the medicine stock management practices at 
those facilities (Harries et al., 2007; Barrington et al., 2010).  In a study by Lufesi et. al (2007) in 
Malawi, the main challenges were the lack of training and supervision of health workers involved in 
medicines stock management from seniors such as district pharmacists as well as the inadequate 
capacity of the health facilities (Lufesi, Andrew & Aursnes, 2007). A survey in various developing 
countries in 2011 revealed that essential medicines used in the management of chronic conditions and 
communicable diseases requiring life-long treatment such as HIV were most prone to stock-outs 
(Cameron et al., 2011; Bigdeli et al., 2014). 
 
In recent years, the world-wide increase in the prevalence of HIV/AIDS and tuberculosis (TB) has 
increased the demand for anti-retroviral (ARVs) and TB medicines (Mayosi et al., 2009; Magadzire et 
al., 2014). Since it has been predicted that the burden of disease in relation to these diseases is likely to 
increase in the coming decades, access to ARVs and TB medicines needs to be increased (Mayosi et 
al., 2009; Health Systems Trust, 2015).The early initiation of anti-retroviral treatment improves health 
outcomes, yet one of the challenges that have been reported from programs on the scaling up of anti-
retroviral treatments to increase access has been the unavailability of ARVs (Kitahata et al., 2009; 
World Health Organisation, 2015). In South Africa, surveys have revealed the extent of stock outs of 
ARVs and TB medicines (Stop Stock Outs Group, 2014; Stop Stock Outs Group, 2015; Public Service 




HIV and TB management in South Africa has been shifted to the Primary Health Care (PHC) level 
which is also the entry point for citizens into the healthcare system. The search for an effective medicine 
stock management system remains a priority for the current government considering that the public 
sector serves more than 70% of the population in South Africa (McIntyre et al., 2009; Public Service 
Commission, 2015). A Discrete Choice Experiment on improving the public health sector in South 
Africa revealed that the availability of medicines at health facilities has the greatest impact in the 
probability that people will attend public health facilities (Honda et al., 2015). Therefore, improving 
the availability of medicines at the PHC level would be a good step for the country as it moves towards 
achieving UHC. The aim of this study was to explore and provide insight into factors influencing the 
availability of medicines through examining the processes involved in medicine stock management at 




Figure 1 provides a conceptual framework of factors influencing medicine stock management processes 
at health facilities and, consequently affecting the availability of medicines. These factors include: (1) 
inventory control, (2) communication, (3) information systems, and (4) the capacity of healthcare 
providers. Inventory control of medicines at the health facilities includes the maintenance of stock levels 
and the processes used to order medicines to ensure uninterrupted availability of medicines (USAID: 
Deliver Project, 2011). Communication refers to the sharing of information in relation to medicine stock 
management and this may be between health workers at the facility as well as with external stakeholders 
such as the suppliers of medicines which in our case is the pharmaceutical depot (Harries et al., 2007; 
Barrington et al., 2010). Information systems include technologies used in managing medicine stock 
and in sharing information (Harries et al., 2007; Barrington et al., 2010). Capacity of health workers 
and the health facility refers to the extent to which the health workers are qualified for medicine stock 
management as well as the extent to which the facility they work in allows them to do so efficiently 
(Lufesi, Andrew & Aursnes, 2007). Where the health facilities are in different areas, contextual factors 
unique to these regions may also influence the processes in medicines stock management (Hasselback 





Figure 1: Conceptual framework showing factors influencing the medicine stock management at 
Primary Health Care (PHC) clinics which in turn may influence the availability of medicines at 
facilities. 
 
Study Design and Setting 
A qualitative multiple case study design was chosen for this study as case studies allow for an in-depth 
description of a certain phenomenon within a particular context (Yin, 2003; Green & Thorogood, 2014). 
The study focused on the factors in medicine stock management which may influence the availability 
of medicines at PHC facilities.  
In this study, a primary healthcare facility is a case and medicine stock management is the unit of 
analysis. As the conceptual framework indicates, the study looks at the four key components of the 
medicine stock management in primary healthcare facilities, namely: (1) inventory control, including 
forecasting of medicine stocks, (2) human resource capacity; (3) information and reporting systems; 
and (4) communication between the depot and clinics. 
South Africa has a National government and nine Provincial governments. Across the nine Provinces 
there are a total of fifty-two health districts. The study province houses three of the fifty-two health 
districts was selected for this study because in 2014 and 2015 it reported the largest proportion of 
facilities with stock-outs of ARVs and TB medicines (Stop Stock Outs Group, 2015). These medicines 
are particularly important in South Africa because of the large burden of disease (Mayosi et al., 2012). 
The most urban district and the most rural district in the province were selected to give insight into 
whether any contextual factors specific to that district such as geographic location may influence the 
medicine stock management.   
 Four clinics were purposively sampled for investigation, a total of two clinics per district were selected. 
They were purposively selected with assistance from the district pharmacist in each district using (1) 
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information on the reported unavailability of medicines by the clinics and (2) the respective district 
pharmacist’s experience in terms of medicine stock management practices at the clinics to include: 
• one clinic that had challenges in medicine stock management in each district. 
• one clinic that was functioning well in terms of medicine stock management in each district 
 
Data collection 
The conceptual framework (Figure 1.), developed from literature reviewed on medicines availability 
and stock management was used to guide data collection as questions for the in-depth interviews were 
derived using key concepts from the conceptual framework, which includes inventory control, 
communication, information systems, capacity and context. The questionnaires (Appendix A) were 
piloted prior to commencement of data collection. The questionnaires were tested for validation on two 
nurses and two pharmacists working in similar settings as those in the study but would not participate 
in the study. Key policy documents related to the medicine stock management at PHC facilities; and 
district organograms were reviewed to identify key informants for interview as well as to describe the 
processes in medicine stock management. Provincial and district organograms and snowballing were 
used to identify the key actors in the medicine stock management at PHC level in both districts. Semi-
structured in-depth interviews were carried out in English and were tape-recorded where the 
interviewees consented. Observation at the facilities on the processes followed by the clinics in 
medicine stock control using a checklist (Appendix B) and a review of Standard Operating Procedures 
on stock management was also part of data collection.   
 
Data processing and analysis 
Recorded interviews were transcribed verbatim into a word document. These transcripts together with 
field notes from observations carried out at the clinics and documentary reviews were analysed using a 
multiple coding process to identify common themes in the cases followed by a cross case analysis. The 
first coding cycle was a deductive process using themes from the conceptual framework, the second 
cycle was inductive to identify additional themes not included in the conceptual framework. NVIVO 
was used to arrange the data and facilitate the coding process. The cross-case analysis involved 
identifying key concepts from each case following the coding process. The cases were analysed to see 
if there were any common concepts amongst them as well as to establish if there were any underlying 
contextual factors which could be responsible for the concepts which were unique to a case. Contextual 





This study obtained ethical approval from the University of Cape Town human research ethics 
committee (HREC Ref: 134/2016). Research approval was obtained from the National and Provincial 
Department of Health committees.  Participation was voluntary and prior to visiting the facilities, letters 
of invitation with information on the objectives and contents of the study were sent to the key 
informants. Before the interviews were conducted, written consent was obtained from the participants 
to participate in the study, for tape recording and the use of their quotations in publications or reports 
on the study.  
 
Medicine stock management guidelines at PHC clinics in the study province 
The provincial government has published a medicine stock management guideline which facilities 
should ideally follow (see Figure 2). Inventory control at the clinics includes various tasks and 
processes. Daily, clinic staff which consists mainly of nurses but in some cases, may be pharmacists or 
pharmacist assistants are required to maintain a running inventory of all medicines by recording stock 
movement on stock cards. These stock cards should indicate the minimum, maximum and re-order 
levels. These levels should guide the determining of quantities of medicines to order from the 
Pharmaceutical Depot (PD).  
Every week, clinics are required to report to the district office on medicines availability by indicating 
which items have been out of stock in the past week.  
Ordering of medicines from the PD is done fortnightly following a schedule provided by the PD. Clinics 
indicate on an order sheet the quantities of the medicines they require and fax it to the PD which 
processes the order and delivers it to the clinics also on pre-determined dates. Upon delivery, the clinics 
should check the medicines received in the order. Any discrepancies should be queried with the PD 
immediately and if needed credits or debits processed. Upon raising the query, if the depot indicates 
that they have stock of medicines ordered but not received by the clinic, the clinic may make an 
emergency order through their feeder hospital and arrange for transport to collect the medicines from 
the PD. If the PD does not have stock, the clinics should inform their clinic supervisor who will cascade 
the information to other supervisors and the PHC managers at the district level who can advise on steps 
to be taken from there.  
Clinic staff are required to review and re-calculate their stock levels if necessary on a quarterly basis 
based on the history of consumption in the past three months. District hospitals were responsible for 




Figure 2: Summary of processes to be followed in medicine stock management at clinics as per Standard 
Operating Procedures for Pharmaceutical Services at PHC level. 
 
Findings 
In this section, the findings on the factors influencing the processes in medicine stock management at 
the clinics are discussed. First we look at the challenges faced by the health workers at the clinics in 
medicine stock management then we move on to give the possible factors why the staff are faced with 
these challenges which may lead to medicine stock outs.   
Challenges faced in the inventory control of medicines at the clinics 
The clinic staff involved in medicine stock management at two of the clinics did not always record 
stock movement on the stock cards. This included recording stock received from orders placed at the 
PD, stock borrowed or lent to other facilities and stock removed from the main bulk storage room to 
the dispensing room/places. Upon receipt of an order from the PD, the clinic staff did not check the 
stock received to ensure it matched the invoices and the order they had placed.  As a result, medicine 
stock levels were not always up to date at these clinics. These two clinics were also the ones which 
according to their district pharmacists reported greater proportions of stock outs. 
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“When they receive stock as well, they don’t reconcile stock with the invoices and record it on 
the stock cards, you see.”- (District Pharmacist A) 
 
At all the clinics, none of the clinic staff reviewed and calculated their stock levels every three months 
using the recommended equation (Min stock=average monthly consumption (AMC) x1.5) even though 
they were aware that they were supposed to do this. The calculations were time consuming and difficult 
for the clinic staff to do.  
“By right like I said we need to be using that method from Pharmacy and it is strenuous for us 
because we, because some Clinic they have Pharmacy assistants people who are there to look 
after the pharmacy so we don't have this person here this clinic is very small so we don't have 
the pharmacy assistant.  So, a nurse needs to see a patient need to go to the pharmacy and 
check if everything is in order, make orders all of that it gets too much for us.”- (Nurse 2, 
District A) 
Forecasting for medicine stock at the clinics was not done using the recommended methods at all the 
clinics and sometimes those making orders would not check stock levels before placing orders at the 
PD to determine re-order quantities but they used their own judgement and experience to determine 
what quantities to order instead of consulting the re-order levels and calculating the amounts needed.  
“To be honest what we do when we are ordering; we go to the pharmacy, we check, oh we have 
got 50 paracetamol and paracetamol goes fast ok I need to order. Ok we do not do that maths 
thing you see. - (Nurse 1, district A) 
 
Factors that could influence the availability of medicines 
Insufficient human resources and the capacity of nurses managing medicine stock. 
Inadequate staffing at clinics and district health offices, and the absence of pharmacists and/or 
pharmacist assistants at clinics emerged as important factors affecting the ability of clinics to undertake 
medicine stock management according to recommended guidelines. Not having an adequate number of 
staff made it difficult for the nurses to carry out their roles in medicine stock management.  
“(…) with the staff shortage, it is difficult to do drug management.” (Nurse 2, district B) 
Even though some of the nurses had the technical capacity to perform medicine stock management, the 
lack of staff meant that they could not do so.  
“I think the nurses know what they are supposed to but they can’t do it because there is no 
staff.” (District Pharmacist B) 
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Nurses had many roles and worked under time constraints as they had other nursing roles. Because of 
this they did not have time for medicine stock management. 
“We find that in other clinics, there are 2 or 3 sisters that are running the whole clinic. Now 
they have to see patients on a day to day basis, you know. They become so busy in such a way 
that other drug supply management duties get ignored in the clinic.” (District Pharmacist A) 
 
In both districts, there was a general feeling that pharmacist assistants or pharmacists should be 
managing medicine supply at the PHC facilities.  
“I think that if we had a pharmacy assistant everything would be perfect I am sure that even 
the pharmacy would be perfect.” (Nurse, PHC 1, District B) 
“If all the clinics can have a pharmacy assistant based in the clinic that could decrease some 
problems.” (PHC supervisor) 
 
Pharmacists and pharmacist assistants would be better than nurses at medicine stock management 
because their training prior to qualification includes medicine stock management unlike the nurses who 
have to be trained on it whilst on the job.  
“The other thing is that nurses were not trained in drug supply management from school. Even 
if we can give them training like workshops after school, or after they have qualified, it doesn’t 
make that much of an impact... So, to have somebody who is trained on drug supply 
management you know, who are custodians of drug supply management it really makes a 
difference at facility level.” – (District Pharmacist B)  
 
It was observed that the two clinics where a pharmacist or pharmacist assistant were employed had up 
to date running inventory compared to the clinics where only nurses managed medicine stock. These 
were also the clinics identified in each district as those facing less challenges in medicines availability 
and had reported less stock outs per their respective district pharmacists.  
Both district pharmacists cited that there were limited funds to employ pharmacist assistants and or 





Information Systems used in the medicine stock management at PHC facilities get in the way of 
health workers as they carry out their duties. 
Information systems include technologies used in managing medicine stock and in sharing information. 
Communication systems used included face-to face, written and electronic exchanges of information.   
 
In both districts, it was observed that the information systems used in managing medicine stock were 
paper based except for one clinic which had the computer based Rx solution® computer program in 
addition to the paper based methods. The clinic which used Rx solution® was one of the clinics in the 
district that did not have many challenges with medicines availability. Rx solution® could not be 
installed at all the clinics as they did not have computers and internet access.  
 
The ordering of medicines from the PD was done manually by clinic staff. An order sheet indicating 
quantities required was faxed to the depot. A challenge faced by two of the clinics was that they did not 
have fax machines on-site and had to send the order to their nearest hospital for it to be faxed to the PD 
from that hospital.  
“Ideally you have a fax machine where we fax the form but we do not have. We order then I 
always go to the hospital, I use my own transport to take the order to the hospital then I fax 
then I get the confirmation of the fax” (Nurse, PHC 3, district B) 
 
This ordering system also did not allow real-time ordering of medicines from the depot as the clinics 
had no access to information on what medicines were available at the time they placed the orders. The 
information systems linking the clinics to the depot were lacking. Internet and computers were not 
available for use at the clinics which limited the depot in terms of sending out information to the clinics 
as e-mails are quick and easy to send out to large groups thus affecting communication.  
“But the only way that the depot can inform facilities is through circulars and through emails 
so the hospital people will always receive emails it will depend on how effective they are to 
cascade it to the PHCs.” (District Pharmacist A) 
Communication between health workers at the clinics and other actors outside the PHC facilities. 
Communication, which refers to the sharing of information between the PHC facility staff and other 
actors which include the district pharmacists, hospitals and the pharmaceutical depot included 
information on medicines that were unavailable at the depot and alternative medicines available or 




The depot was of the perception that there were no problems in communication between them and the 
PHC facilities. According to them, they frequently communicated with the clinics.  
“On a daily basis, I would say, there is always something that we must write to the clinics. I 
think weekly there is something going to the clinics, either via the district hospitals or the 
hospitals but eventually to the clinics.” (Pharmaceutical Depot manager) 
 
Ideally the information should flow from the Head of Pharmaceutical Services or depot to the district 
pharmacists and hospitals. This flow of information was efficient because both levels had computers 
with access to the internet allowing them to use emails to communicate and send circulars to the district 
pharmacists and hospitals. The district pharmacists and hospitals were then responsible for passing the 
relevant information to the PHC facilities. However, this flow of information was not efficient and this 
was articulated by all the interviewees, partly because of the lack of information systems that allowed 
this e.g. computers and internet.  
“There is a huge communication gap [between the clinics and the depot]. But between the 
depot and the hospitals the flow of information is going very very well. Now the forms or let me 
say the platforms of communications between the depot and the facilities [hospitals], they 
normally use emails most of the time. And the quickest way that you can send a circular out is 
via email.  So, you find out that hospitals do have information of a particular drug that is out 
of stock and then it will depend on how effective that particular hospital is in informing the 
clinics that they are supervising. You see if they are effective enough then the clinics that they 
are supervising will be aware that maybe 3TC 300mg is out of stock.” (District Pharmacist A) 
 
Due to the challenges in infrastructure, the depot could only send hard copies of the circulars to the 
clinics when they delivered medicines to them which was every two weeks. This meant that if the 
information was only relevant at the time the circular was released, the clinics may receive it when it is 
no longer relevant. 
“Well I think with circulars; it takes forever because someone needs to sign and stuff like that 
... Sometimes they will come here probably after they were signed last month and you don't 
know if this is still valid because it was 20 days ago, when it was sent to us.” (Pharmacist, PHC 




The depot did not communicate directly with the clinics providing them with reasons why they had not 
fulfilled the complete orders placed by the clinics. Clinics often had to initiate contact with the depot to 
find out why they had not received certain medicines that they had ordered.  
“You have ordered a set item but when you receive the stock there is nothing and there is no 
reason. They just put the zero, no stock on the order form but there is no reason why. So now 
you have to follow up with them and call them asking why have we not receive this.” 
(Pharmacist, PHC 2, District A) 
 
Because of all this, some of the clinics felt that the communication between them and the depot was not 
sufficient.  
“If I can rate them, not now, the depot, no man, no they do not communicate with us… in our 
situation we always find that we are the ones who are always on their case finding out what 
could have happened with the stock and stuff like that they have never made an effort.” (Nurse, 
PHC 3, District A) 
 
Supervision and support from the district level in terms of medicine stock management at PHC 
facilities may be lacking. 
The feeder hospitals and district pharmacists were unable to visit the clinics often and thus clinics did 
not always receive adequate supervision from them to ensure that procedures particularly SOPs in 
medicine stock management were being implemented. This affected the communication between the 
clinics and their respective district pharmacists whose role was to co-ordinate medicine supply. The 
clinics did not always send information on the availability of medicines on a weekly basis as they were 
required to.  
 
The district pharmacists left it up to the feeder hospitals to ensure that the clinics received support 
however this did not always happen. The lack of supervision from feeder hospital pharmacists was due 
to insufficient human resource at the hospitals to send pharmacists to support clinics as well as resources 
such as vehicles for these pharmacists to use.  
“We don't have enough hands, enough people, skilled people to actually do the trainings, to 
monitor, do monitoring and evaluation at facility levels.” (District Pharmacist A) 
Contextual factors that may influence the medicine stock management which are beyond the 
control of the clinics. 
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Limited physical resources such as computers, fax machines, and facility vehicles were a challenge for 
all the clinics except one. These resources would make it easier for clinic staff to fulfil their tasks in 
managing medicine stock, for example sending orders to the depot.  
“Ok we have most of, how can I put it, in other facilities they complain about resources. We 
are lucky enough to have such resources such as photo copy machines.” (Pharmacist, PHC 2, 
district A) 
Infrastructure and space at the clinics for the storage of medicines was also lacking. This was a major 
problem at two out of the four clinics, the dispensing rooms were very small and at one clinic medicines 
were stored in cabinets in the nurses’ consulting rooms. These clinics could therefore not store extra 
emergency stock 
“You see this locker is small we are trying to fit; we are trying but everything should be there 
and then it is small It cannot accommodate everything...  Even our pharmacy room it is small 
like a toilet it is very small. Only one person can enter in that old building.” (Nurse, PHC 1, 
district A) 
HIV treatment is provided at PHC level and the changing of guidelines to provide ART to all regardless 
of CD4 count increased the influx of patients visiting clinics for services. Thus, clinics are busier and 
need to adjust their stock levels to meet the demand for ART.  
“The burden of disease comes above our efforts to fight stock outs; it increases the influx of 
patients into the facilities whilst there are shortages from the supplier or the suppliers are 
unable to cope with the demand.” (Study province, Head of Pharmaceutical Services) 
 
Clinics that were situated closer to the depot or their feeder hospital found it easier to collect medicines 
from the depot when they had placed an emergency order compared to those further away.  
“With X hospital, yes that is a little bit convenient for me because we are very close so I can 
jump in the car and quickly go there, and I have my own transport. Many of the other clinics 
you know the pharmacist assistants maybe don't have their own transport they use taxis or they 
are too far from X hospital it can be a challenge for them.” (Pharmacist assistant, PHC 4, 
district B) 
 
How the clinics/health workers have adapted to cope with the challenges faced. 
The health workers have relationships with health workers from other facilities which enable them to 
communicate and borrow stock from each other. Since not all facilities had access to working 
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telephones, clinic staff used WhatsApp to communicate with each other. This method of communication 
was fast. 
“We have a WhatsApp group, for operational managers and for the whole district team where 
we discuss, because sometimes others do not have landlines and what, what, but we use the 
WhatsApp group and we liaise there, and you get help like that” (PHC supervisor) 
The clinic staff also made sacrifices, such as working extra time so that they can finish their tasks and 
ensure that all tasks in medicine stock management have been completed. 
“I know of one sister who puts in more time to stock management. She will go to the facility on 
a Saturday just to make sure that she places her order accurately. So, it's up to the OM or the 
person responsible for that to do that, but it's not like they have to do that, they just go that 
extra mile.” (Pharmaceutical Depot manager) 
 Another sacrifice made was the use of their private vehicles to collect medicines for patients when the 
clinic itself was unable to provide transport for this. 
“The government does not provide cars actually to use around I do not know why it is like that 
but it's hard because I feel for the person because they become your family all of a sudden you 
feel for them and then you are like know let me the sacrifice for them once. 1L will make a 
difference. It helps if you have a car because if you didn't have it, it would be a different story, 




The study examined actual practice in how primary healthcare facilities manage medicine stock and 
identified key factors influencing the occurrence of medicine stock outs by specifically looking at: 
inventory control; human resources available for medicine stock management at primary health 
facilities; information systems and reporting mechanisms; and communication between clinics and 
other health systems actors. The factors that may influence the occurrence of stock outs include 
medicine stock levels not being kept up to date at the clinics and not using the recommended methods 
of forecasting when placing medicine orders from the PD. This may have been due to lack of capacity 
in terms of physical resources as well as human resources both at the clinics themselves and at the 
district level from which oversight and support of medicine stock management should have come from. 
Other challenges faced by health workers involved in medicine stock management at primary health 
facilities which may have contributed to the occurrence of stock outs include insufficient information 
systems which affected communication between primary healthcare facility workers and other 
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important stake holders such as the district hospital pharmacists and pharmaceutical depot thus limiting 
the clinic staff from managing medicine stock efficiently.  
One of the common practices found at the clinics was that of poor inventory control. Inventory control 
is a very important aspect of medicine stock management at the health facility level (Githinji et al., 
2013; Mikkelsen-Lopez et al., 2014). If stock levels are not up to date then it would be easy to miss 
items that need to be ordered when they need to be ordered and this often leads to medicine stock 
running out at the clinics (Mikkelsen-Lopez et al., 2014). In addition to not having stock levels up to 
date, the health workers were not following the recommended forecasting methods which could have 
also contributed to the occurrence of stock outs. A structured forecasting system is essential to ensure 
uninterrupted medicine availability (Harries et al., 2007).  
The lack of human resources at public health care facilities is one of the main factors contributing to 
the frequent unavailability of medicines at PHC clinics. Where there is a shortage of human resources, 
health workers may be unable to perform their duties adequately (Lufesi, Andrew & Aursnes, 2007). 
Most of the clinics were not adequately staffed and did not have pharmacist assistants which led to 
nurses undertaking the medicine stock management. These nurses constantly worked under time 
constraints, preventing them from following procedures according to the medicine stock management 
SOP. The nurses felt as though medicine stock management was not meant to be their responsibility 
but rather that of pharmacy personnel such as pharmacists and pharmacist assistants. Due to the human 
resource crisis in health care, task-shifting has become a common practice in resource constrained 
settings (Hongoro & McPake, 2004; Fulton et al., 2011). Task-shifting is the allocation of tasks within 
the healthcare system to health workers who would not normally do those tasks but can do them 
(Hongoro & McPake, 2004). It is often less costly to employ these workers (Hongoro & McPake, 2004). 
Some countries and some disciplines have resorted to the use of mid-level cadres to bridge the gap in 
human resources (Lehmann, 2008). However, the challenge with task-shifting as we see from our 
findings is that the nurses were not adequately trained to perform medicine stock management and did 
not receive sufficient supervision by seniors such as district pharmacists or district hospital pharmacists 
(Lufesi, Andrew & Aursnes, 2007). Supervision by district pharmacists was reported to have reduced 
the occurrence of medicine stock outs in a study carried out in Malawi where nurses were responsible 
for medicine stock management (Githinji et al., 2013).   
 
Another factor that contributed to medicine stock outs was the gap in communication between the 
personnel at the clinics and those at PD which is essential in managing medicine stock because vital 
information needs to be shared between them (Barrington et al., 2010). The PD was of the impression 
that they had communicated to the clinics by sending circulars to them bi-weekly and relying on the 
district level to pass on urgent circulars they would have received via email (Bateman, 2013). Studies 
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found that where communication between stakeholders involved in medicine stock management was 
efficient, less stock outs occurred (Berger et al., 2007). Strategies to mitigate medicine stock outs have 
included focusing on on-line information systems use in the process of managing medicine stock thus 
countries are moving from paper based methods of communication and managing medicine stock to 
electronic systems (Berger et al., 2007; Barrington et al., 2010). In our study, we found that the current 
information systems limited the health workers in terms of communication. These systems used in 
ordering did not allow for real-time ordering where the health worker at the facility could instantly 
know if a medicine they had ordered was out of stock. Access to such information could allow the 
health worker to immediately place an order for the alternative medicines unlike in the case of the 
clinics where they would find out when their order had been delivered that the PD did not have stock 
of that medicines and it may be too late to place an order for alternatives at that time and the clinic runs 
out of medicine.  
One way of addressing the human resource challenge would be the use of more pharmacist assistants 
at the clinics for medicine stock management. These pharmacist assistants would work under the 
indirect supervision of pharmacists at the district hospitals. This would allow nurses to focus more on 
their nursing duties and not have to prioritise when they are pressed for time. The training of PHC 
nurses at nursing colleges before they are qualified could also include medicine stock management so 
that they are better equipped to manage medicine stock. Continual professional development on 
medicine stock management could also be made mandatory for health workers working at the clinics 
as this would ensure that the health workers’ knowledge on medicine stock management is up to date.  
To improve communication, the use of cell phones to send circulars from the PD on medicine 
availability may be useful since it has been identified that the clinics do not have access to emails 
because they do not have computers unlike at the district level. The NDoH has recently introduced the 
Stock Visibility Solution (SVS) with the aim of improving the reporting of medicine availability by 
PHC staff using cell phones to capture and send this information to the district level. This is similar to 
the SMS for life program that improved the availability of rapid diagnostic tests and anti-malarial 
medicines by enhancing stock visibility in Kenya (Githinji et al., 2013). Since these systems involve 
the use of cell phones, the pharmaceutical depot could send urgent circulars on medicine availability 
via SMS to health workers rather than hand delivered circulars. There is an increasing trend in the use 
of mobile health technologies to facilitate the sharing of information in the healthcare system amongst 
health workers as well as to patients (Chib, van Velthoven & Car, 2015). Another solution would be to 
equip the PHC clinics with computers so that the Rx solution for stock management may be 
implemented there. Linking this system to the depot to allow real time ordering of medicines would 
also alleviate the problem of finding out that there is no stock at the depot only when the order is 




To improve the medicine stock management at PHC facilities and avoid medicine stock outs, 
government could consider the following policy recommendations, which are based on the findings 
from the study. 
 Training of nurses on forecasting methods and other aspects of medicine stock management 
should be included in the nursing curriculum at nursing colleges.  
 Continuous monitoring and supervision of nurses working in medicine stock management by 
district pharmacists on the implementation of SOPs on medicine stock management.  
 Strengthening human resources at PHC facilities by employing more people-particularly 
pharmacist assistants/ technicians to work at clinics so that nurses are relieved of medicine 
stock management duties.  
 Equipping the PHC facilities with necessary communication infrastructure e.g. computers as 
this will allow more of them to use Rx solution for medicine stock management and if internet 
is available, they would be able to use emails to communicate. Rx solution should also be set 
up with a real-time ordering system linking PHC facilities to the depot. This system would 
allow them to access information on medicines available for order as they place the order.  
 Using cell phones to send circulars on medicine availability via SMS to health workers rather 
than hand delivered circulars as this would convey the information much faster. 
 
Conclusion 
One of the disadvantages of case studies is that the results cannot be generalised as they are specific to 
a context, however the findings from this study provide insight into areas for government focus to 
improve medicine availability in South Africa and other countries with similar settings. A major 
limitation of this study was that the clinics were not consistent in reporting medicine availability to their 
respective district pharmacists and so the information they had on medicine stock outs at the clinics was 
incomplete. Therefore, the purposive sampling may have been done using incomplete data. This 
information would have also added value to our findings as it would then be possible to quantify the 
occurrence of stock outs and use this as a comparison. Other limitations of this study include the fact 
that PHC staff were warned of the research visits therefore they could have done things a particular way 
because they were aware that someone would be doing research in the facility. Lastly, the interview 
questions collected data from the health workers which was based on past experiences which may be 
subject to recall bias. One of the strengths of this study is that stakeholders from different levels of the 
health system were interviewed that is from the PHC, district and provincial level. This allowed us to 
get different perspectives which is valuable in research. More than one source of data was used which 
allowed for triangulation and this is one of the ways in which qualitative researchers increase rigour.  
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Whilst many studies have focused on the factors that influence medicine availability at the higher levels 
such as the suppliers of medicines which in our case would be the pharmaceutical depot, this study 
focused on what may influence it on the ground, the PHC clinic level. The study is important because 
if medicine is available at higher levels but challenges are experienced at the lower levels, then medicine 
stock outs will still occur. Our study provides insight into practical issues that can be addressed at the 
PHC level in order to improve medicines availability. Future research in medicine stock management 
in the South African context could be conducted on how mobile health technologies could be utilised 
to a greater extent in medicine stock management particularly to link the PHC facilities with the 
pharmaceutical depot and other stakeholders allowing them to freely share information. It would also 
be beneficial to explore the acceptability of these technologies by the health workers required to use.  
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This policy brief was prepared by Fadzai Munedzimwe as 
part of a dissertation for a Master of Public Health degree 
at the School of Public Health & Family Medicine of the 
University of Cape Town. The project was funded by the 
National Research Fund (NRF) South African Research 
Chair; Health and Wealth program and was also supported 
by the National Department of Health of South Africa. 
INTRODUCTION 
The unavailability of essential medicines at health 
facilities is a major barrier to accessing medicines in 
many Low and Middle-Income Countries (LMICs) 
(Schouten et al., 2011; Wagenaar et al., 2014). South 
Africa has a high burden of disease in relation to HIV 
and TB and the medicines used to manage these 
conditions are some of those medicines which are most 
prone to stock outs (Cameron et al., 2011; Bigdeli et 
al., 2014; Stop Stock Outs Group, 2015). The 
availability of medicines used to manage HIV and TB 
needs to be improved as it has also been predicted that 
the burden of disease in relation to these communicable diseases is likely to increase in the coming decades 
(Mayosi et al., 2009; Health Systems Trust, 2015a). One of the challenges that have been reported from programs 
on the scaling up of anti-retroviral treatments to increase access has been the unavailability of ARVs (Kitahata et 
al., 2009; World Health Organisation, 2015). Research on improving the public health sector in South Africa 
revealed that the availability of medicines at health facilities has the greatest impact on the probability that people 
will attend public health facilities (Honda et al., 2015) The search for an effective medicine stock management 
system remains a priority for the current government considering that the public sector serves more than 70% of 
the population in South Africa (McIntyre et al., 2009; Public Service Commission, 2015). Furthermore, the PHC 
level needs to be prioritised as it is the entry point for citizens into the healthcare system (McIntyre et al., 2009; 
Bigdeli et al., 2014). In this policy brief, we present the findings from a study that aimed to identify factors 
influencing the occurrence of medicine stock outs in PHC facilities through examination of medicine stock 
management practices at PHC facilities.  
Key Findings 
 Medicine stock outs occur because Standard
Operating Procedures on medicine stock
management are not being followed. 
 Standard Operating Procedures are not
followed because of the lack of sufficient and
adequately trained human resources at the 
clinics as well as lack of oversight from the 
district. 
 Gaps in communication and lack of
infrastructure also affected medicine stock 
management. 
 Health workers adapt to the contexts they work
in and develop ways of coping with the 
challenges they face ensure that patients receive 
medicines.  
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Methods 
Figure 1. Conceptual framework showing factors influencing the medicine stock management at Primary 
Health Care (PHC) clinics which in turn may influence the availability of medicines at facilities. 
A qualitative multiple case study approach was used 
to explore the factors which may influence medicine 
stock management at four PHC facilities. Based on 
the following selection criteria, two districts were 
chosen from a province in South Africa: (1) the 
district that had reported the least and the greatest 
frequency of stock outs of ARVs and TB medicines 
and (2) the reported availability of medicines at the 
facilities in the selected districts. Semi-structured 
interviews were conducted with key stakeholders 
involved in medicine stock management at PHC 
facilities including the facility, district and 
provincial levels. Observations at the health 
facilities as well as document reviews were also 
used to collect data. The main themes raised in the 
questionnaires were from a conceptual framework 
(see Figure 1.) developed on the basis of literature 
on medicine stock management and the causes of 
stock outs. The factors that influence the medicine 
stock management processes at health facilities thus 
affecting the availability of medicines include the 
inventory control of medicines, capacity of the 
health facility and health workers, information 
systems used and communication between health 
workers involved in the management of medicine 
stock.  
Findings 
What factors influence the availability of 
medicines at PHC facilities? 
 Management of HIV at PHC level and the
changing of guidelines to provide ART to all
regardless of CD4 count increased the influx
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of patients visiting PHC facilities for services. 
Thus, clinics are busier and need to adjust their 
stock levels to meet the demand for ART.  
“The burden of disease comes above our 
efforts to fight stock outs; it increases the influx 
of patients into the facilities whilst there are 
shortages from the supplier or the suppliers are 
unable to cope with the demand.” (Head of 
Pharmaceutical Services) 
 The health workers managing medicine stock 
were aware of the processes they needed to 
follow as set out in the Standard Operating 
Procedures. However, they were unable to do so 
due to the factors identified below. As a result 
of not following forecasting methods such as 
placing orders using updated stock levels, 
medicine stock outs occurred. 
“To be honest what we do when we are 
ordering; we go to the pharmacy, we check, oh 
we have got 50 paracetamol and paracetamol 
goes fast ok I need to order. Ok we do not do 
that maths thing you see.”(Nurse 1, district A) 
Why are health workers unable to follow 
recommended procedures? 
 Most of the health facilities examined lack the 
qualified pharmacists and pharmacy assistants, 
which results in nurses, who already have a 
heavy workload, managing medicine stock in 
spite of a lack of training for this work.   
“The other thing is that nurses were not 
trained in drug supply management from 
school. Even if we can give them training like 
workshops after school, or after they have 
qualified, it doesn’t make that much of an 
impact... So, to have somebody who is trained 
on drug supply management you know, who are 
custodians of drug supply management it really 
makes a difference at facility level.”  (District 
Pharmacist)  
 There were gaps in communication between 
health workers at the PHC facilities and 
external stakeholders such as the 
pharmaceutical depot which supplied them with 
medicines and the district hospitals which were 
responsible for supervising them. As a result of 
this, the PHC facilities did not receive memos 
from the depot about medicines availability in 
time for them to act accordingly.  
“There is a huge communication gap 
[between the clinics and the depot]. But 
between the depot and the hospitals the flow of 
information is going very very well. Now the 
forms or let me say the platforms of 
communications between the depot and the 
facilities [hospitals], they normally use emails 
most of the time. And the quickest way that you 
can send a circular out is via email.  So, you 
find out that hospitals do have information of a 
particular drug that is out of stock and then it 
will depend on how effective that particular 
hospital is in informing the clinics that they are 
supervising. You see if they are effective enough 
then the clinics that they are supervising will be 
aware that maybe 3TC 300mg is out of stock. 
(District Pharmacist) 
 Infrastructure and space at the clinics for the 
storage of medicines was also a challenge at two 
out of the four clinics, the dispensing rooms 
were very small and at one clinic medicines 
were stored in cabinets in the nurses’ consulting 
rooms. These clinics could therefore not store 
extra emergency stock.  
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“You see this locker is small we are trying to fit; 
we are trying but everything should be there and 
then it is small it cannot accommodate everything...  
Even our pharmacy room it is small like a toilet it is 
very small. Only one person can enter in that old 
building.” (Nurse, PHC 1, district A) 
How do the clinics/health workers adapt to cope 
with the challenges they face? 
The health workers have relationships with health 
workers from other facilities which enables them to 
communicate and borrow stock from each other. 
Since not all facilities had access to working 
telephones, clinic staff used WhatsApp to 
communicate with each other. This method of 
communication was fast. 
“We have a WhatsApp group, for 
operational managers and for the whole district 
team where we discuss, because sometimes others 
do not have landlines and what, what, but we use 
the WhatsApp group and we liaise there, and you 
get help like that.” (PHC supervisor) 
Policy recommendations 
To improve the medicine stock management at PHC facilities and avoid medicine stock outs, government should 
consider the following policy recommendations, which are based on the findings from the study. 
 Training of nurses on forecasting methods and other aspects of medicine stock management should be
included in the nursing curriculum at nursing colleges.
 Continuous monitoring and supervision of nurses working in medicine stock management by district
pharmacists on the implementation of SOPs on medicine stock management.
 Strengthening the human resources at PHC facilities by employing more people-particularly pharmacist
assistants/ technicians to work at clinics so that nurses are relieved of medicine stock management duties.
 Equipping the PHC facilities with necessary communication infrastructure e.g. computers as this will allow
more of them to use Rx solution for medicine stock management and if internet is available, they would be
able to use emails to communicate. Rx solution should also be set up with a real-time ordering system linking
PHC facilities to the depot. This system would allow them to access information on medicines available for
order as they place the order.
 Using cell phones to send circulars on medicine availability via SMS to health workers rather than hand
delivered circulars as this would convey the information much faster.
Conclusion 
In conclusion, unlike many studies which focused on medicine availability at higher levels for example 
manufacturers and suppliers on the availability of medicines, this study provides insight into practical issues 
that can be addressed at the PHC level in order to improve medicine stock management.  This is most important 
because if medicines are available at the pharmaceutical depot but medicine stock management is inefficient 
at PHC facilities, stock outs may still occur.  
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APPENDIX 1: INFORMATION SHEET 
Medicine stock management at Primary Health Care facilities 
Medicines are vital in the provision of healthcare therefore it is essential for them to be available in 
sufficient quantities at all times. Primary Health Care (PHC) clinics are the entry point for most citizens 
into the South African health care system and it is of great importance to ensure that medicines are 
available at clinics. The availability of medicines has been found to be an important deciding factor 
used by patients when choosing to seek care from health facilities and is therefore a priority for the 
South African government as it aims to strengthen its health system.  
The aim of this study is to better understand the process of managing medicine stock at public health 
facilities in District A and District B in the study province. The study will have a specific focus on the 
PHC level by examining the processes used by the clinics to manage medicine stock and how the clinics 
interact with the pharmaceutical depot in this process. It will also look into factors which may influence 
the management process. 
We would be most grateful if you could take part in this study by sharing your experiences in the 
management of medicine stock at clinics in the study province. The interview will take about 1 hour. 
You are free to decide whether or not to participate at any point and time throughout the duration of the 
study. You may also choose not to answer a particular question(s) and you can stop the interview at any 
time. The information that you provide will be kept confidential and will be combined with the 
responses from the other interview participants. No one will know what you, or any other individual 
have said and no personal details will appear in any reports generated from this research.  
We hope that this study will reflect on the opinions from health workers like your-self and inform policy 
review and formulation of standard operating procedures for the management of essential medicines in 
public health facilities.  
We value your opinion and would be most grateful if you choose to participate in this study. If you 
require more information on the study, we would be pleased to provide you with more information and 
answer any questions that you may have with regards to the study and your participation.  
Yours sincerely,  
Fadzai Munedzimwe 
MPH (Health Economics) student, Health Economics Unit,  
School of Public Health and Family Medicine, University of Cape Town 
Tel: +27 21 406 6558 Email: Fadzai.munedizmwe@gmail.com 
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APPENDIX B: CONSENT FORM 
Medicine stock Management at Primary Health Care facilities 
Consent to participate in interviews and for tape recording 
I have been informed about the study ‘Managing medicine stock at Primary Health Care facilities in 
District A and District B in the study province, South Africa’ and have had the opportunity to ask 
questions about the study and my involvement in it.  
I understand that there will be no consequences as a result of my participating, or not participating in 
the interviews and recording of the interviews. 
I understand that my participation is voluntary and that I am free to withdraw at any time and request 
that the interview is not tape recorded, without giving a reason.  
I understand that the information I provide will be treated in the strictest confidence and that my name 
will not be used when the information is analysed and reported. 
I agree to take part in the interview. Yes/No 
I agree to the tape recording of the interview. Yes/No 
I agree for my quotations to be used in the publication or report released on the study. Yes/No 
Signature of the participant Date 
Interviewer’s name (please print) 
Interviewer’s signature Date 
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APPENDIX C: QUESTIONNAIRES 
Semi-structured questions for key informant interviews 
Individual interviews with health workers in charge of medicine management at PHC clinics. 
Capacity of the health workers and facility 
 Please provide me with some insight on how medicine stock is managed in the clinic?
(Who is involved, how were they appointed, are the sufficient people?)
 Do you think there are enough people involved in the management of medicine stock?
If yes, or no, please explain.
 Have you received any specific training or mentoring on inventory control or medicines
stock management i.e. on how to use the stock cards or computer systems? (this training
may include in-service training/mentorship)How often does this happen? From
where/whom do you receive the training/mentoring and when last did it happen? Did
the training better equip you to carry out your roles in medicine stock management? If
there were any gaps, please mention them.
 How often does the district pharmacist/pharmacists visit the clinic? What is the purpose
of these visits? What do you think about the visits? How does this help you in terms of
stock management? Is there anything that could be done to improve this? If he never
visits, do you think he should visit?
 Do you have telephone lines, internet access, computer systems at the facility in order
for you to use to communicate with the depot and other clinics/ district/ provincial
offices? Are these in working order? Do they give you any trouble?
Stock management processes/Inventory control, forecasting and information systems 
 Can you please show me how and where you record the stock levels of medicines? At
each point in time, roughly how much stock of a specific medicine do you keep at your
facility? How do you determine these quantities? How often do you review the stock
levels to ensure that they are sufficient? (ask for a copy of stock control sheet/stock
card)
 Can you please explain to me the process you follow when ordering stock?
 How often do you order medicines from the pharmaceutical depot?
 After how long do you receive your order from the depot? Who is responsible for
transporting the medicines you have ordered from the depot to your facility?
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 Do you receive stock from anywhere other than the depot? If so, where do you receive
it from and how to you order it? Why do you receive stock from other sources?
 Who is responsible for receiving stock upon delivery? What is the process for receiving
stock at the facility? How do you ensure that what you have ordered is the same as what
you have received from the depot?
Relationship and communication with the pharmaceutical depots 
 Does the depot inform you if a certain medicine is unavailable and they are unable to
supply it? If so how do they inform you? Does the depot give you an indication of when
the medicine may be available again?
 What do you think about the way you communicate with the depot? Could you please
discuss things that work well and if there are challenges what challenges do you face
any challenges in communicating with the depot? What do you think can be done to
improve the way in which you interact and communicate with the depot?
Drug stock outs response 
 When medicines run out at your clinic or are not delivered from the depot, what is the
first thing you do? Who do you contact and how do they respond?
 Do you make any efforts to source medicines that are out of stock from another
clinic/hospital? Where would you source medicines that are out of stock at the clinic?
Who is responsible for transporting these medicines you have sourced from another
clinic/hospital to your clinic?
 If a medicine is out of stock, what do you give the patient? Do you substitute the
medicine? What do you base your substitution on? Do you receive any guidelines on
which medicines you can substitute with in the case of a nation-wide stock out?
Context 
 Does the distance from the depot pose any challenges for medicine stock management?
If yes, what are these challenges? Have any of these challenges been resolved in the
past?
 Have there been any recent changes to drug stock management in your district?
 Do you feel that if you were closer to the depot things might be better? If yes/ no, why?
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 Do you ever experience any challenges with late deliveries from the depot? What is the
cause of these late deliveries? Do you experience any transportation challenges with
regards to deliveries from the depot?
 What do you think about the location of the clinic in terms of accessibility? What made
you choose to work at this facility? Are you still enjoying working here?
 Is it easy or hard to do drug stock management in this facility? What factors help or
hinder this in the facility?
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Semi-structured questions for key informant interviews 
Individual interviews with district pharmacists. (2) 
Stock management processes at the clinics. 
 Can you please tell me about your role as the district pharmacist in ensuring the
availability of medicines at PHC clinics?
 How often do you check the stock levels at the clinics and in what way?
 Do you ever assist or send pharmacists or pharmacist assistants to assist the clinics in
managing their stock?  How do you or the pharmacists/ pharmacist assistants assist and
how often?
 Do you train or ensure that nurses at the clinics are able to manage stock levels? If you
do, how often and in what way is this done?
 What do you think influences the medicine stock management process at clinics? What
could be done to improve the management of medicine stock at clinics?
Relationship between clinics and the pharmaceutical depots 
 How do you communicate with the pharmaceutical depot? What is the purpose of the
communication? How often do you communicate?
 Do you communicate with the depot on behalf of the clinics? If so, what is the purpose
of this communication?
 Does the depot inform you if a certain medicine is unavailable and they are unable to
supply it? If so how do they inform you? Does the depot give you an indication of when
the medicine may be available again? Do you disseminate this information to the
clinics? How do you do this? What challenges do you face in doing this and how could
they be dealt with?
 What do you think about the communication between clinics and (1) the district office
(2) the depot?
 What do you think could enable better information sharing and communication?
Drug stock outs response 
 How do you find out about medicine shortages and stock outs as they happen at the
clinics? How do you respond?
 Do you make any efforts to source medicines that are out of stock at a particular clinic
from another facility (clinic/hospital/district)? If so from where?
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 If a medicine is out of stock at the depot, do you receive any guidelines on which 
medicines you can substitute with in the case of a nation-wide stock out? How do you 
disseminate this information? 
 Why do you think medicine stock outs occur at clinics? 
Context 
 In what ways do you think geographic location influences the availability of medicines at 
clinics? Do you find that there is a difference between the capacity of health workers to manage 
medicine stock at the rural and urban clinics? If there is a difference what do you think causes 
this difference? 
 In your opinion, does the burden of disease affect the processes of medicine stock management? 
If so, how? 
 Does the distance between your office and the clinic have any effect on the extent to which you 




Semi-structured questions for key informant interviews 
Individual interviews with the provincial head of pharmaceutical services. (1) 
Stock management processes at the clinics. 
 Please tell me about your role as the head of pharmaceutical services in the province in
ensuring the availability of medicines at PHC clinics?
 Do you check the stock levels at the clinics? How often do you do this? What is the
purpose of the checks?
 Do you train or ensure that nurses at the clinics are able to manage stock levels? If so,
how often are the nurses trained and in what form is the training (formal or informal
e.g mentoring)?
 What factors do you think influence the management of stock at clinics?
Relationship between clinics and the pharmaceutical depots 
 How do you communicate with the pharmaceutical depot? How often do you
communicate? Do you communicate with the depot on behalf of the clinics? If so, what
is the purpose of this communication?
 Does the depot inform you if a certain medicine is unavailable and they are unable to
supply it? Does the depot give you an indication of when the medicine may be available
again? Do you disseminate this information to the clinics? How do you do this?
 Are you aware of how clinics communicate with the depot? What do you think about
this communication and the way in which they interact? Do you see any challenges or
enablers of good communication?
Drug stock outs response 
 Do the clinics alert you of medicine shortages and stock outs as they happen at the
clinics? If not how do you find out about them? How do you respond when you find
out?
 Do you make any efforts to source medicines that are out of stock at a particular clinic
from another facility? Where would you source these medicines?
 If a medicine is out of stock at the depot, do you prepare any guidelines on which
medicines can be used as substitutes? How do you disseminate this information to the
clinics?
 In your opinion, what do you think are the enablers of good medicine stock
management? What do you think causes stock outs at the clinic level?
Context 
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 In what ways do you think geographic location influences the availability of medicines
at clinics? Do you find that there is a difference between the capacity of health workers
to manage medicine stock at the rural and urban clinics? If there is a difference what
do you think causes this difference?
 In what way do you think the distance between a facility and the depot is related to the
occurrence of drug stock outs?
 In what way is the burden of disease related to the occurrence of stock outs?
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Semi-structured questions for key informant interviews 
Individual interviews with pharmaceutical depot manager 
Stock management processes at the clinics. 
 Can you please tell me about your role as the responsible pharmacist at the depot in
ensuring the availability of medicines at PHC clinics?
 Please tell me about the process you follow when fulfiling an order from the clinics?
Do you use a manual or computer based system for this? Please tell me how it works.
 What factors do you think influence the process of medicine stock management at
clinics?
 Do you receive information on stock levels at the clinics? How often and in what way?
 Do you train or ensure that nurses at the clinics are able to manage stock levels/use
stock control tools? If so, how often and in what way is this done?
 In terms of DDV’s what is your role in ensuring that there is timely delivery of
medicines at the clinics? Do you communicate to the clinics about expected delivery
dates of stock that they have ordered?
 How are medicines delivered to the clinics? Is there a schedule, route for delivery? Are
you obliged to communicate with the clinics with regards to changes in the schedule?
Who is responsible for this and how do they ensure that the communication has reached
the facilities? How do you ensure that medicines have reached the clinics after their
dispatch at the depot?
Relationship between clinics and the pharmaceutical depots 
 How do you communicate with the clinics? Email, fax, telephone? Are there dedicated
channels for orders, queries etc.?
 Do you communicate with regards to stock levels with the district pharmacist/ head of
pharmaceutical services on behalf of the clinics? If so, what is the purpose of this
communication?
 What are the strengths and weaknesses in the way in which you communicate with
clinics? What do you think can be done to address the weaknesses?
Drug stock outs response 
 Do the clinics alert you of medicine shortages and stock outs as they happen at the
clinics? If not how do you find out about them? What is your response when you find
out?
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 Do you make any efforts to facilitate the sourcing of medicines that are out of stock at
a particular clinic from another clinic/hospital? Where and how would you source these
medicines?
 Who do you inform if a certain medicine is unavailable and are unable to supply it to
the clinics? How do you inform them? Do you give you an indication of when the
medicine may be available again? Do you send any guidelines on which medicines the
clinics can substitute with in the case of a nation-wide stock out? How do you
disseminate this information?
 What do you think causes medicine stock outs at the clinics?
Context 
 In what ways do you think geographic location influences the availability of medicines
at clinics? Do you find that there is a difference between the capacity of health workers
to manage medicine stock at the rural and urban clinics? If there is a difference what
do you think causes this difference?
 Do you experience any transportation challenges when delivering stock to clinics
further away from the depot? (E.g. accessibility)
 Are there any differences that you have noticed in the medicine ordering patterns
between clinics in District A and District B? If yes, what do you think causes this?
 In what way is the burden of disease related to the occurrence of stock outs?
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APPENDIX D: OBSERVATION AND FIELD NOTES FORM 
District:   Facility Number: 
Storage space (no stock on the floor or in places not ideal as medicine rooms) Yes No 
Notes: 
Are stock levels indicated on bins? Yes No 
Notes: 
Are stock cards being used in dispensing rooms? Yes No 
Notes: 
Are stock cards being used in bulk store rooms? Yes No 
Notes: 
Check balance on stock cards with quantity on hand for two random items. Yes No 
Notes: 
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APPENDIX E: UCT ETHICS APPROVAL LETTER (HREC)
Signature removed
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APPENDIX F: PROVINCIAL DEPARTMENT OF HEALTH APPROVAL
Signature removed
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APPENDIX G: JOURNAL INSTRUCTIONS FOR AUTHORS
Health Policy and Planning improves the design, implementation and evaluation of health 
policies in low- and middle-income countries through providing a forum for publishing high 
quality research and original ideas, for an audience of policy and public health researchers 
and practitioners. HPP is published 10 times a year. 
HPP has a double-blinded peer-review policy. All types of papers are peer reviewed and all 
article abstracts from each issue are translated into French, Spanish and Chinese. 
 Guidance
 Types of papers
 Submission process
Guidance 
Improving chances of publication 
As well as the high overall quality required for publication in an international journal, authors 
should take into consideration. 
 Addressing HPP's readership: national and international policy makers, practitioners,
academics and general readers with a particular interest in health policy issues and debates.
 Manuscripts that fail to set out the international debates to which the paper contributes, and to
draw out policy lessons and conclusions, are more likely to be rejected, returned to the authors
for redrafting prior to being reviewed, or undergo a slower acceptance process.
 Economists should note that papers accepted for publication in HPP will consider the broad
policy implications of an economic analysis rather than focusing primarily on the
methodological or theoretical aspects of the study.
 Public health specialists writing about a specific health problem or service should discuss the
relevance of the analysis for the broader health system. Those submitting health policy analyses
should draw on relevant bodies of theory in their analysis, or justify why they have not, rather
than only presenting a narrative based on empirical data.
 Primarily focus on one or more low- or middle-income countries.
The editors cannot enter into correspondence about papers considered unsuitable for 
publication and their decision is final. Neither the editors nor the publishers accept 
responsibility for the views of authors expressed in their contributions. The editors reserve the 
right to make amendments to the papers submitted although, whenever possible, they will seek 
the authors' consent to any significant changes made. The manuscript will not be returned to 
authors following submission unless specifically requested. 
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Should you require any assistance in submitting your article or have any queries, please do not 
hesitate to contact the editorial office at hpp.editorialoffice@oup.com. 
Manuscript format and style for all articles 
Only articles in English are considered for publication. 
Prepare your manuscript, including tables, using a word processing program and save it as 
a .doc, .rtf or .ps file. Use a minimum font size of 11, double-spaced and paginated throughout 
including references and tables, with margins of at least 2.5 cm. The text should be left justified 
and not hyphenated. 
The title page should contain: 
 Title - please keep as concise as possible and ensure it reflects the subject matter
 Corresponding author's name, address, telephone/fax numbers and e-mail address
 Each author's affiliation and qualifications
 Keywords and an abbreviated running title
 2-4 Key Messages, detailing concisely the main points made in the paper
 Acknowledgements
 A word count of the full article
In the acknowledgements, all sources of funding for research must be explicitly stated, including 
grant numbers if appropriate. Other financial and material support, specifying the nature of the 
support, should be acknowledged as well.  
Figures should be designed using a well-known software package for standard personal 
computers. If a figure has been published earlier, acknowledge the original source and submit 
written permission from the copyright holder to reproduce the material. Colour figures are 
permitted but authors will be required to pay the cost of reproduction.  
Please be aware that the requirements for online submission and for reproduction in the 
journal are different: (i) for online submission and peer review, please upload your figures 
separately as low-resolution images (.jpg, .tif, .gif or. eps); (ii) for reproduction in the journal, 
you will be required after acceptance to supply high-resolution .tif files. Minimum resolutions 
are 300 d.p.i. for colour or tone images, and 600 d.p.i. for line drawings. We advise that you 
create your high-resolution images first as these can be easily converted into low-resolution 
images for online submission.  
Figures will not be relettered by the publisher. The journal reserves the right to reduce the 
size of illustrative material. Any photomicrographs, electron micrographs or radiographs 
must be of high quality. Wherever possible, photographs should fit within the print area or 
within a column width. Photomicrographs should provide details of staining technique and a 
scale bar. Patients shown in photographs should have their identity concealed or should have 
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given their written consent to publication.  
When creating figures, please make sure any embedded text is large enough to read. Many 
figures contain miniscule characters such as numbers on a chart or graph. If these characters 
are not easily readable, they will most likely be illegible in the final version. 
Certain image formats such as .jpg and .gif do not have high resolutions, so you may elect to 
save your figures and insert them as .tif instead.  
For useful information on preparing your figures for publication, go 
tohttp://cpc.cadmus.com/da . 
All measurements should be reported in SI units, followed (where necessary) by the traditional 
units in parentheses. There are two exceptions: blood pressure should be expressed in mmHg and 
haemoglobin in g/dl. For general guidance on the International System of Units, and some useful 
conversion factors, see 'The SI for the Health Professions' (WHO 1977).  
Manuscript file must include text body. Title Page, Figures and Tables should be uploaded 
separately. 
Manuscript Preparation 
Page 1: Title Page – as above; 
Page 2: Abstract. The abstract should be prepared in one paragraph, no headings are 
required. It should describe the purpose, materials and methods, results, and conclusion in a 
single paragraph no longer than 300 words without line feeds.  
Page 3: Introduction. The Introduction should state the purpose of the investigation and give 
a short review of the pertinent literature, and be followed by:  
Materials and methods. The Materials and methods section should follow the Introduction 
and should provide enough information to permit repetition of the experimental work. For 
particular chemicals or equipment, the name and location of the supplier should be given in 
parentheses.  
Results. The Results section should describe the outcome of the study. Data should be 
presented as concisely as possible, if appropriate in the form of tables or figures, although 
very large tables should be avoided. 
Discussion. The Discussion should be an interpretation of the results and their significance 
with reference to work by other authors.  
Abbreviations. Non-standard abbreviations should be defined at the first occurrence and 
introduced only where multiple use is made. Authors should not use abbreviations in 
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headings. 
References. References must follow the Harvard system and must be cited as follows: 
Baker and Watts (1993) found...  
In an earlier study (Baker and Watts 1993), it...  
Where works by more than two authors are cited, only the first author is named followed by 
'et al.' and the year. The reference list must be typed double-spaced in alphabetical order and 
include the full title of both paper (or chapter) and journal (or book), thus:  
Baker S, Watts P. 1993. Paper/chapter title in normal script. Journal/book title in 
italics Volume number in bold : page numbers.  
Baker S, Watts P. 1993. Chapter title in normal script. In: Smith B (ed). Book title in italics. 
2nd edn. Place of publication: Publisher's name, page numbers.  
Up to five authors should be cited. If there are more, cite the first three authors and follow 
with 'et al.', e.g.:  
Baker S, Watts P, Smith B et al. 1993. Paper title in normal script. Paper presented at 
meeting/conference title, place, date. Unpublished document.  
Tables All tables should be on separate pages and accompanied by a title - and footnotes 
where necessary. The tables should be numbered consecutively using Arabic numerals. Units 
in which results are expressed should be given in parentheses at the top of each column and 
not repeated in each line of the table. Ditto signs are not used. Avoid overcrowding the tables 
and the excessive use of words. The format of tables should be in keeping with that normally 
used by the journal; in particular, vertical lines, coloured text and shading should not be used. 
Please be certain that the data given in tables are correct. Tables should be provided as Word 
or Excel files. 
Types of papers 




 Research in practice
 Commentaries
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 'How to do (or not to do)...' [for example, see Hutton & Baltussen, HPP, 20(4): 252-
9 ] and 
 '10 best resources' [for example, see David & Haberlen, HPP, 20(4): 260-3 ].
 Supplements
ORIGINAL RESEARCH 
Manuscripts should preferably be a maximum of 6000 words, excluding tables, 
figures/diagrams.  
The manuscript will generally follow through sections: Title page (as above), Abstract (no 
more than 300 words), Introduction, Methods, Results, Discussion, Conclusion, 
Acknowledgements, References. However, it may be appropriate to combine the results and 
discussion sections in some papers. Tables and Figures should not be placed within the text, 
rather provided in separate file/s. 
For the reporting of statistical analyses please consider the following additional points: 
 Focus the statistical analysis at the research question.
 Report simple analyses first, then only more sophisticated results.
 Provide information about participation and missing data.
 As much as possible, describe results using meaningful phrases (e.g., do not say "beta" or
"regression coefficient", but "mean change in Y per unit of X"). Provide 95% confidence
intervals for estimates.
 Report the proportions as N (%), not just %.
 Report P values with 2 digits after the decimal, 3 if <0.01 or near 0.05 (e.g., 0.54, 0.03, 0.007,
<0.001, 0.048). Do not report P values greater than 0.05 as "NS".
 Always include a leading zero before the decimal point (e.g., 0.32 not .32).
 Do not report tests statistics (such as chi-2, T, F, etc.)."
For acknowledgements, figures and measurements see above. 
